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CHAPTER 1 
GENERAL INTRODUCTION -
THE RENAL BASEMENT MEMBRANES - ALPORT'S SYNDROME 
1.1. STRUCTURE AND FUNCTION OF RENAL BASEMENT MEMBRANES 
In the kidney, basement membranes are extracellular structures, 
separating, in glomeruli, endothelial and epithelial cells. They are 
supposed to be derived from both cell lines (Sanóla et al., 1984; 
Abrahamson, 1985). They consist of collagenous and non-collagenous 
glycoprotpins. The collagenous glycoproteins are mainly localized in 
the lamina densa, whereas the lamina rara interna and externa 
(localized at the endothelial and the epithelial side of the basement 
membrane respectively) contain the largest amount of non-collagenous 
proteins. Some authors consider, however, these inner and outer lamina 
as a fixation artifact, due to tissue-processing, and assume no 
differences in composition (Catchpole, 1982; Laurie et al., 1983, 
1984; Simpson, 1986). The tubular basement membrane, synthesized by 
the tubular cells, has a composition different from the glomerular 
basement membrane (Langeveld, 1981; Langeveld et al., 1981). Structure 
and function of the basement membranes have been reviewed by Grant et 
al. (1981) and by Rand-Weaver and Price (1983). 
A number of functions have been attributed to the basement 
membranes. The three most important ones will be shortly discussed 
here. Basement membranes provide mechanical support to the surrounding 
tissue (Krakower et al., 1978). They form the resistant scaffold of 
glomeruli and tubules. Secondly, this scaffold is necessary for the 
formation and development of the tissue (Vracko, 1974). Finally, 
basement membranes possess semipermeable properties, which are 
important for the glomerular filtration and tubular handling of the 
filtrate. Biophysiology of glomerular filtration has been excellently 
reviewed (Kanwar, 1984). The semipermeability of the glomerular 
basement membrane is size- and charge-selective, as was established by 
the classical experiments of Brenner et al. (Bohrer et al., 1978; 
Fig. 1). 
Charge selectivity is mainly produced by the negative charge of the 
basement membranes, due to the presence of heparan sulfate, but also 
acid groups of amino acid residues and sialic acid may contribute 
(Farquhar et al., 1985). The negatively charged sialoglycoprotein 
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Fig. 1.1: Fractional clearances of cationic diethylaminoethyl (DEAE) 
dextran, neutral dextran, and anionic dextran sulfate, 
plotted as a function of effective molecular radius in 
normal rats. Taken from Bohrer et al., 197Θ, with 
permission. 
podocalyxin, present in the plasma membranes of podocytes, also has a 
role in the charge-dependent barrier (Charest and Roth, 1985; 
Kerjaschki, 1985; Kunz et al., 1985). Negatively charged serum 
proteins, such as albumin, are hampered in their passage through the 
membrane. 
1.1.1. COLLAGENOUS GLYCOPROTEINS 
Collagen is wide-spread found in the human body. This glycoprotein 
is characterized by high contents of glycine (33% of all amino acids) 
and of 4-hydroxyproline (about 10% of all amino acids). More than 10 
types of collagen have been isolated and identified on the basis of 
differences in their polypeptide subunits or α-chains. Most abundant 
is type I, which contains two a-jd) chains and one 02(1) chain and 
is predominantly present in bone, tendon and skin. Type II (3 αϊ(II) 
chains) occurs in cartilage, and type III (3 αι(ΙΙΙ) chains) in fetal 
skin and blood vessels. These collagen types form fibrils, after 
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splitting off their terminal peptide 
collagen fibers is summarized in Fig. 2. 
H j « . 
-i> 
Inlrocelluloi Sttpi 
1 ДіиілЫу ol 3 Polypeptide 
«RN* chonsof ^ t 300ooieach 
2 Synlhesu o( pqnidyl Hypra 
Опб Hylys 
3 A<Miionotsuqars(Glc Gol ) 
10 Hylys 
4 SynllwsiS ol nlerchotn 
S ^ ^ ^ ^ - ^ y ^ 5 Formol w'of 3 M l < 
g/P'Vimó'M'l 'mb^Ï^^ 
« Sec el OP of Pfecunof ("Prwollogen") 
Refnovol ol Peptide Eileneonl 
sS* fe^s^seSs; 
nf of Tibef 
1 DeOm nol ОП ol Hylyt ond Lf S № 
g ve aldehydes 
2 C'OSS I nh lormol on by r.ocl v* of 
e Iher lo) 2 aldéhydes of lb) 
aldehyde * I NH^ on adjacenl 
extensions. Biosynthesis of 
After intracellular assembly 
of the polypeptide 
chains hydroxylation 
of proline and lysine, 
and glycosylation 
of hydroxylysine 
three chains form the 
typical triple helix 
structure, which is 
excreted as procollagen 
out of the cell. After 
removal of the extension 
peptide fibers can be 
formed and cross-linked. 
Fig. 1.2: Biosynthesis of collagen fibers. 
Basement membranes contain another type of collagen, type IV. There is 
no agreement whether type V is an integral basement membrane component 
(Rand-Weaver and Pnce, 19B3). The main differences in amino acid 
composition of the chains of the 5 collagen types mentioned are 
summarized in Table I. 
The collagen type IV molecules are approximately 400 nm in length. 
They consist of three different polypeptide-chains, two a-|(IV) chains, 
and one 0 2 ^ ^ ^ chain (Dean et al., 19B3). These chains are formed 
from approximately 1700 amino acid residues, of which every third is 
glycine. The extension peptides are not split off during collagen IV 
synthesis. The constituent procollagen-chains form a 1400 residue long 
triple helix, which is frequently interrupted by non-helical regions, 
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Table 1.1: Composition of human collagen chains. 
Collagen type 1 II III IV V 
Denotation chain «HjÜ) «2(1) *1<Π) *l(III) "lÜV) Ö^ÜV) «A *tB 
3-Hydpoxyprollne 
A-Hydroxyprollne 
Proline 
Glycine 
Hydronylyslne 
Lysine 
1.1 
IIA 
118 
330 
m 
27 
1.2 
105 
114 
331 
12 
20 
2 
99 
121 
333 
M 
22 
N.H. 
125 
107 
350 
5 
30 
β 
123 
58 
35Α 
52 
7 
7 
112 
55 
3*Ä 
41 
5 
2 
109 
97 
319 
24 
18 
3 
109 
118 
322 
35 
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Amino acids are given as residues per 1000 amino acid residues. N.R. = 
not reported. Table has been modified from Langeveld (19Θ1); data were 
collected from the literature (Miller 4 Lunde, 1973; Chung & Miller, 
1974; Burgeson et al., 1976; Dixit, 1980). N.R. = not reported. 
causing great flexibility of the segment and protease-sensitivity. One 
of the short triple-helical regions at the amino-terminal end of the 
molecule, the 75 collagen domain, is very rich in carbohydrates, and 
is an important cross-linking region of type IV collagen (Risteli et 
al., 1990; Kühn et al., 1981). The 75-domain connects four type IV 
collagen molecules. A second part of the collagen molecule, the NCI 
globular domain, located at the other end of the molecule, connects 
two collagen molecules (Timpl et al., 1981; Oberbäumer et al., 1985). 
These two connecting domains, the 7S-collagen and the NCI globular 
domain, are responsible for the amorfous appearing structure of the 
basement membrane (Fig. 3). 
Type IV collagen is characterized by its high content of 
hydroxylated derivatives of proline and lysine, and by its high 
content of carbohydrates. The content of the 3-hydroxyproline-isomer 
is also remarkable. The hydroxylysine present in the basement membrane 
is for about 70% glycosylated with galactose and glucose (Spiro, 
1967a; Fig. 4 ) . The glomerular basement membrane of man has a higher 
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Fig. 1.3: Model of the association of type IV collagen molecules in 
the basement membrane matrix. Taken from Timpl et al., 1981, 
with permission. 
content of 3-hydroxyproline compared to the tubular basement membrane 
(Langeveld et al., 1981). The chemical composition of the renal 
basement membranes changes with maturation. The extent of hydroxy-
lation of proline and lysine increases with age in both types of renal 
basement membranes. An adult level is reached for the glomerular 
basement membrane after 4-7 months and for the tubular basement 
membrane after approximately 10 years (Langeveld et al., 1981). A 
decrease of the extent of hydroxylation of lysine and proline is 
observed in senescence (Langeveld et al., 1984). 
1.1.2. NON-COLLAGENOUS GLYCOPROTEINS 
A number of non-collagenous proteins are associated with or present 
in basement membranes. The most important of them are fibronectin, 
lamimn, and proteoglycans. Minor constituents are entactin, nidogen, 
and amyloid P. Entactin is a sulfated glycoprotein (M
r
 = 158,000), 
probably serving for adhesion between cellular and extra-cellular 
material (Bender et al., 1981). Amyloid Ρ and nidogen are other 
glycoproteins, with unknown function (Dyck et al., 19Я0а; Timpl et 
14 
al., 198^). Abnormalities are observed in renal pathology (Dyck et 
al., 1980b). 
Fibronectin 
Structure and function of fibronectin have been extensively revie-
wed (McDonagh, 1981; Mosher and Furcht, 1981; Ruoslahti et al., 1981; 
Vartio, 1983). Fibronectin is a high molecular weight glycoprotein 
(Mr= 440,000), that binds to collagen and to proteoglycans. It is an 
adhesive protein that serves as a molecular glue between cells and 
basement membranes. It is an important mediator for regeneration after 
tissue damage. In most glomerular diseases an increase of the fibron-
ectin content in the glomerulus is observed (Dixon et al., 1980). 
Laminin 
Laminin, a cross-shaped glycoprotein, probably functions as a 
mediator between collagen and heparan sulfate in basement membranes 
and their adherent cells (Timpl et al., 1983a; Kleinman et al., 1985; 
Von der Mark and Kühl, 1985). It is localized mainly in the laminae 
rarae of the basement membrane. 
Proteoglycans 
Proteoglycans are negatively charged macromolecules which consist 
of a core protein of variable size, to which one or more qlycosamino-
glycan side chains are bound. Excellent recent reviews of their 
structure and function are available in the literature (lozzo, 1985; 
Kuettner and Kimura, 1985; Poole, 1986; Gallagher et al., 1986). There 
are different qlycosaminoglycan chains, of which chondroitin sulfate, 
keratan sulfate, and heparan sulfate are the most important ones. 
These chains are responsible for the negative charge of the 
proteoglycan. In the glomerular basement membrane heparan sulfate 
proteoglycans are predominantly present. They are mainly localized in 
the laminae rarae (Schurer et al., 1978; Kanwar and Farquhar, 1979). 
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Chondroitin sulfate proteoglycans are confined to the mesangial 
matrix. Glomerular basement membranes have a higher glycosaminoglycan 
content than tubular basement membranes in most mammals, but in man 
only in the neonatal period (Reubsaet et al., 19 5а, Ь), Their 
relative content in the glomerular basement membrane decreases until 
the age of 2.5 years. 
The proteoglycans of the basement membrane, together with sialic 
acid and the sialoglycoproteins present on the surface of the 
podocytes, are responsible for the so-called anionic sites (Klein et 
al., 1983). Changes in the anionic sites in the glomerular basement 
membrane have been described in glomerular diseases associated with 
proteinuria. Firstly, this was noticed in aminonucleoside nephrotic 
rats. Reduced staining of the glomerular basement membrane with 
colloidal iron, alcian blue, and lysozyme was observed (Michael et 
al., 1970; Caulfield, 1978; Caulfield and Farguhar, 1978). The loss of 
these anionic sites seems to be due to a loss of sialic acid (Blau and 
Michael, 1972; Quatacker, 19Θ6) and of proteoglycans (Mynderse et al., 
1983; Klein et al., 1984). Others, using electron microscopic 
autoradiography with ^Si.cationic ferritin, were unable to 
demonstrate an alteration in the anionic sites in aminonucleoside 
nephrosis (Kanwar and Jakubowski, 1984). With the use of dextran 
clearances, changes in the anionic sites could be demonstrated in 
nephrotoxic serum nephritis in the rat (Brenner et al., 1978). In man, 
changes in the anionic sites in the laminae rarae have been reported 
in the congenital nephrotic syndrome (Vernier et al., 1983). Using the 
cationic probe polyethyleneimine, a reduced binding and a change in 
the spacing of the proteoglycan lattice was observed. In the minimal 
change nephropathy an altered glomerular charge could be estimated 
from calculations on filtration dynamics (Carrie et al., 1981; Bridges 
et al., 1982). Recently, a decrease in anionic sites in renal tissue 
of 5 patients suffering from minimal change nephropathy was observed, 
with the use of polyethyleneimine (Mahan et al., 1985). Recent 
investigations suggest that this minimal change nephropathy is a 
consequence of charge neutralization by circulating cationic proteins 
(Barratt et al., 1986). An analogous mechanism may be present in 
patients with systemic lupus erythematosus in whom glomerular deposits 
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of neutrophilic cationic proteins have been demonstrated (Camussi et 
al., 1982). Finally, a reduced content and an abnormal distribution of 
the anionic sites have been observed in diabetic nephropathy, with the 
application of the poly-cationic dyes ruthenium red and polyethyl-
eneimine on the renal biopsy specimens (Rohrbach, 19B6). 
1.1.3. BASEMENT MEMBRANE DEGRADATION 
Little is known about the degradation of basement membranes. In the 
rat complete turnover of the glomerular basement membrane has been 
shown to take at least more than 100 days, using a long-term, 
sequential, electron-microscopic study after labeling with silver 
(Walker, 1973) or a study with radiolabeled amino acids (Price and 
Spiro, 1977). Some non-collagenous compounds have a more rapid 
turnover, as biologic half-life of radioactive sulfate in basement 
membranes is about 7 days (Cohen and Surma, 19B2). There is no 
information about the renal basement membrane turnover in man, neither 
in health nor in disease. 
Basement membrane collagen is specifically degraded by a type IV 
collagenase which is a metalloproteinase. It is produced by 
polymorphonuclear leukocytes and endothelial cells (Mainardi et al., 
1980; Kalebic et al., 19Θ3). This enzyme is supposed to be localized 
on or in the cell membrane. In vitro experiments showed that 
polymorphonuclear leukocytes adhered to human glomerular basement 
membrane surface after its impregnation with IqG. The lysosomal 
enzymes serin proteinase, elastase and cathepepsin G were detectable 
in the medium and digestion of the basement membrane was observed 
(Vissers et al., 1984). Proteinases were also isolated from rat mast 
cells (Woodbury and Neurath, 1980) and human kidney cortex (Thomas et 
al., 1980). The mechanism of action of all these proteolytic enzymes 
with respect to the basement membrane in physiological conditions in 
man remains to be elucidated. An a-glucosidase plays a role in the 
degradation of the hydroxylysine-linked disaccharlde units (Sternberg 
and Spiro, 1979; Hamazaki and Hotta, 1980). A sialidase was isolated 
from rat kidney cortex (Cohen-Forterre et al., 1985). 
Three components, originating from the degradation of the basement 
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membrane collagen and detectable in the urine, namely the two 
hydroxylysylglycosides and 3-hydroxyproline, will be described in more 
detail. 
During collagen biosynthesis some hydroxylysine residues undergo 
galactosylation and subsequent glucosylation to give a diglycoside, 
glucosylgalactosylhydroxylysine (Spiro, 1967a, Ь). in this process a 
galactosyltransferase and a glucosyltransferase are involved (Spiro 
and Spiro, 1971). The biological significance of these saccharidic 
units on the collagen molecule is not completely clear. A possible 
role in the prevention of cross-links formation has been suggested 
(Yamauchi et al., 1982). Glycosylation of hydroxylysine residues is 
supposed to prevent their oxidative deamination to aldehydes, thereby 
precluding formation of cross-links. Basement membrane collagen type 
IV is the most abundantly glycosylated collagen. 
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Fig. 1.4: Molecular structure of α-D-glucosyl- S-D-galactosyl-
hydroxylysine 
About 70й of the hydroxylysine of collagen IV is glycolysated, in 
contrast to about 33% in bone and skin collagen. There are also 
differences in the ratio of glucosylgalactosylhydroxylysine and 
galactosylhydroxylysine between the collagen types (Table II). The 
predominance of the disaccharide-unit in the glomerular basement 
membrane is obvious. 
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Table 1.2: Ratio of glucosylgalactosylhydroxylysine/galactosylhydroxy-
lysine in collagen of skin, bone and glomerular basement 
membrane. 
Ratio Reference 
Skin 2.06 Pinnell et al., 1971 
Bone 0.47 Pinnell et al., 1971 
Glomerular basement membrane 3.7 Sternberg et al, 1979 
Several methods have been described for the determination of the 
glycosides in the urine (Kakimoto and Akazawa, 1970; Segrest and 
Cunningham, 1970; Lou and Hamilton, 1971; Askenasi, 1973; Sato et al, 
1976; Krane et al, 1977; Bisbee and Kelleher, 1978; DiFerrante et al., 
1980). The urinary glycosides can originate from all collagen types 
and from the complement component Piq, which has a similar composition 
as basement membrane collagen (Reíd, 1979; Shinkai and Yonemasu, 
1979). In diseases involving collagen, the excretion of the glycosides 
may be increased. In this respect the hydroxylysylglycosides can be 
compared with the well-known collagen marker 4-hydroxyproline. An 
increased excretion of galactosylhydroxylysine has been reported in 
Paget's disease, an increased excretion of glucosylgalactosylhydroxy-
lysine in extensive destruction of skin (Askenasi, 1974; Askenasi et 
al., 1976; Kelleher, 1979). This resulted in a decrease and an 
increase respectively in the glucosylgalactosylhydroxylysine/galacto-
sylhydroxylysine-ratio in the urine. An increased excretion of the 
hydroxylysylglycosides was found in neuroblastoma (Shimizu and 
Labrosse, 1968), uremia (Dubovski et al., 1977), spinal cord injury 
(Rodriguez and Claus-Walker, 1984), and Turner's syndrome (Lanzza et 
al., 1985), a decreased excretion in diabetes mellitus (Sato et al., 
1980). The unique composition of the basement membrane, with a high 
glycosylation grade of hydroxylysine and a predominance of the 
disacchande unit, makes investigation of the urinary hydroxylysyl-
glycosides in glomerular basement membrane diseases interesting. Two 
studies were reported on glycoside-excretion in Alport's syndrome. 
Tina et al. (1979) established an increased excretion of the 
glycosides, with a normal ratio between them. In the control groups 
19 
(nephrotic syndrome, benign Familial hematuria and membranoproli-
Ferative glomerulonephritis) a normal excretion pattern was observed. 
Veltischev et al. (19Θ3) conFirmed the increased excretion rates, as 
were observed by Tina et al. (1979), and Found an increased GGH/GH-
ratio, as theoretically expected. In both these studies Free hydro-
xylysylglycosides were analyzed. Investigation oF the peptidebound 
Fraction, which attributes approximately 105ί oF the urinary glycosides 
in normals, might be more speciFic because its GGH/GH-ratio 
approximates more the values oF the glomerular basement membrane 
(Askenasi et al., 1976). In rats with Masugi-nephritis an increased 
excretion oF the peptide-bound hydroxylysylglycosides was observed 
(Sternberg et al., 1979). 
Since basement membrane collagen (Type IV) is relatively rich in 
3-hydroxyproline as compared to the other collagen types, this amino 
acid might be another marker for renal basement membrane diseases, and 
investigation oF its urinary excretion could be worthwile. Several 
methods For the determination oF 3-hydroxyproline in the urine have 
been described (Adams et al., 1978; Szymanovics et al., 1979; Tseng et 
al., 1980; Bellon et al, 1982; Bisker et al., 1982; Davis Lin, 1982; 
Bellon et al, 1983, 1984; Lindblad and Diegelmann, 1984). Only the 
group oF Borei studied the urinary 3-hydroxyproline-excretion in renai 
disease. They reported an increased excretion in active glomerulo­
nephritis and polykystic kidney disease (Chanard et al., 1980). In 
Alport's syndrome, the 3-hydroxyproline excretion was normal 
(GrünFeld, 1985). 
1.2. ALPORT'S SYNDROME 
1.2.1. HISTORY AND CLINICAL FEATURES 
Alport's syndrome is an inherited disease, with aFFection of 
various organ systems, oF which the kidney, the ear, and the eye are 
the most predominantly aFFected ones. Because the extent of renal 
damage determines the future of these patients, attention has been 
focused on the kidney. Alport's syndrome was first described by 
Guthrie (1902), who observed hematuria in 12 patients out of 2 
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generations from one family. Alport (1927) studied the next generation 
of the same family, and noticed the combination of hematuria and 
hearing loss, together with endstage renal disease in male patients. 
In 1961 Williamsson suggested the name "Alport's syndrome" for the 
disease. The name "hereditary nephritis" is also used rather 
frequently for the syndrome, but should be considered misleading, 
since many disorders of the kidney can be ranged under this 
description. 
The most frequent initial symptom of the disease is hematuria, 
either recurrent or persistent. Periods of macroscopic and microscopic 
hematuria can alternate. Hematuria can be increased by physical 
exercise or intercurrent infections. Many patients with Alport's 
syndrome have initially been diagnosed as acute post-infectious 
glomerulonephritis, because of combined occurrence of hematuria and 
respiratory infection. Hematuria is probably present from birth, 
although only few newborns with the syndrome have been described 
(Gubler et al., 1981). Proteinuria is absent in the early stages of 
the disease and glomerular filtration is normal. In later stages 
proteinuria may occur. The nephrotic syndrome develops in 30-40S of 
the patients (Felts, 1970; Grünfeld et al., 1973; Gubler et al., 
1981). 
In the second decade of life deterioration of renal function 
occurs. Men are more severely affected than women, and present 
endstage renal disease at the age of 20-40 years (Grünfeld et al., 
1973). In women, generally renal failure does not occur, although 
families with early endstage renal disease in women have been 
described (Kaufman et al., 1970; Ferguson and Ranee, 1972). The 
intersexual difference in severity and the variable expression among 
affected women remain poorly understood. Gross hematuria in childhood, 
nephrotic syndrome and diffuse glomerular basement membrane thickening 
by electronmicroscopy are suggestive for progressive disease in 
females (Grünfeld et al., 1985). The genetic features will be 
discussed later (1.2.З.). 
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Auditory involvement concerns a symmetrical progressive sensorineu-
ral hearing loss, more often into the high and middle frequencies. 
There is a marked variation in the degree of hearing loss, usually 
appearing during the second decade, when frequently a sensorineural 
hearing loss of about 50 dB, most marked in the higher frequencies, is 
found. Children below 10 years of age usually have normal hearing at 
audiometrie testing (Klotz, 1959; Johnson and Hagan, 1965; Dubach et 
al., 1966, Gekle et al., 1969; Turner, 1970; Spear et al., 1970). 
Incidence of hearing loss in individual patients is difficult to 
assess since audiological studies of all affected members are rare. 
The hearing loss occurs in most affected males (60%), but also in a 
smaller proportion of females (405a) (Cassady et al., 1965; Chiricosta 
et al., 1970; Ferguson and Ranee, 1972; Hauser, 1979). Extensive 
audiological testing suggests, that the hearing loss is cochlear in 
origin (Spear et al., 1970; Miller et al., 1970). Caloric stimulation 
shows decreased response of the vestibular system (Miller et al., 
1970; Celes-Blaubach et al., 1974). 
Reports concerning temporal bone pathology in Alport's syndrome do 
not show constant findings. Light microscopic and electron microscopic 
findings are available (Gregg et al., 1963; Babai and Bettez, 1968; 
Fujita and Hayden, 1969; Miller et al., 1970; Myers and Tyler, 1972; 
Westergaard et al., 1972; Bergstrom et al., 1972; Weidauer and Arnold, 
1976, Arnold, 1980; Johnson and Kaufman Arenberg, 1981). A diagramma-
tic representation of the anatomy of the organ of Corti is shown in 
Fig. 5. 
Degeneration of the stria vascularis and hair cells of the organ of 
Corti, particularly in the basal turn of the cochlea, has mainly been 
observed as a pathologic correlate of the hearing loss. These findings 
are not specific for Alport's syndrome. Some authors were unable to 
find temporal bone changes characteristic of Alport's syndrome. It is 
also not always clear if or to what extent the dialysis and the 
ototoxic drugs contributed to the cochlear pathologic 
characteristics. Recent investigations stressed the presence of strial 
atrophy and sometimes selective inner hair cell degeneration (Weidauer 
and Arnold, 1976; Arnold, 1980; Johnson and Kaufman Arenberg, 1981). 
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SCAtA TYWPAM 
Fig. 1.5; Organ of Corti (Diagrammatic Representation). From: K.J. Lee 
- The otolaryngology boards, The Medical Examination 
Publishing Cie, Flushing, USA, 1973, with permission. 
These changes in the stria vascularis are considered to be causative 
to the degeneration of the hair cells. Strial atrophy is commonly 
associated with sensorineural degeneration. It occurs in presbyacusis, 
various forms of hereditary deafness, after noise exposure and after 
administration of ototoxic drugs in experimental animals (Johnsson and 
Kaufman Arensberg, 1981). The damage of the stria vascularis in 
Alport's syndrome could be the result of a direct effect of the kidney 
disease itself or a result of shared biochemical abnormality between 
the kidney and the cochlea (Arnold, 1980). This aspect of the disease 
deserves more study. 
Various ocular defects have been described in Alport's syndrome. 
They involve the lens, the retina and the cornea (Sabates et al., 
1983). Bilateral anterior lenticonus is rather characteristic for the 
syndrome (Arnott et al., 1966; Nielsen, 1978; Govan, 1983; Sabates et 
al., 1983). The etiology is unknown, but lenticonus appears to develop 
by a forward bulging of the anterior cortex due to a pathologically 
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thinned basement membrane. Cataract may develop in the course of the 
disease (Faggioni et al., 1972; Govan, 1983). More recently attention 
has focused on the macular and penmacular changes in Alport's syn-
drome (Polak 4 Hogewind, 1977; Perrin et al., 1980; Zylbermann et al., 
1980). 
Fig.1.6; Light micrograph of retina (macula area) (H4E, X390). ILM, 
internal limiting membrane; NFL, nerve fiber layer; GC, 
ganglion cell layer; IPL, inner plexiform layer; INL, inner 
nuclear layer; OPL, outer plexiform layer (P, plexiform 
portion; H, obliguely oriented Henle fibers); MLM, middle 
limiting membrane; ONL, outer nuclear layer; XLM, external 
limiting membrane; RC, laver of rods and cones (IS, inner 
segments; OS, outer segments). From: T.D. Duane and E.A. 
Jaeger - Clinical Ophthalmology. Harper and Row, 
Philadelphia, 1985, with permission. 
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According to Perrin et al. (1980) these changes are present in ¿i0% of 
the cases. The anatomy of the retina and its basement membranes is 
shown in Fig. 6. 
Whitish dot-like lesions are located in the most superficial layer of 
the retina, at the level of the internal limiting membrane (ILM in the 
figure), an ocular basement membrane. In addition in the mid-periphery 
occasionally small flecks can be observed in the retinal pigment 
epithelium (Peterson and Albert, 1974; Govan, 1983). The retinal 
lesions do not produce functional visual disturbance, and have a high 
association with lenticonus and a worse renal prognosis. They seem to 
be rather characteristic for Alport's syndrome. Finally, posterior 
polymorphous dystrophy of the cornea was reported (Sabates et al., 
1983). This can also be called basement membrane pathology, as 
Descemet's membrane shows abnormal thickening and multilaminar 
alterations. 
Many other abnormalities have been associated with Alport's 
syndrome, most of them probably coincidental: hyperprolinemia and 
prolinuria (Efrom, 1965; Goyer et al., 1968), ichthyosis (Goyer et 
al., 1968), mental retardation (Fischer et al., 1970), high СзЬ 
concentration in serum (Teisberg et al., 1973), IgA-deficiency (Simon 
et al., 1977) and defects in proximal renal tubular function (Passwell 
et al., 1981). Macrothrombocytopathia and thrombocytopenia seem to be 
associated with Alport's syndrome (Epstein et al., 1972; Eckstein et 
al., 1975; Parsa et al., 1976; Brivet et al., 1981). In the patients 
studied, megakaryocytes in bone marrow were abnormal. They tend to be 
normal in number, but vary in size, and have a diminished blebbing 
activity. A prolonged bleeding time was reported, as well as an 
impaired aggregation of platelets in response to collagen, ADP, 
epinephrine, and ristocetine in most patients. In one family Brivet et 
al (1981) observed the May-Hegglin anomaly (macrothrombocytopenia with 
cytoplasmic inclusions in the granulocytes (Dohle bodies)). Recently 
Peterson et al. (1985) observed an unique ultrastructural appearance 
of granulocytes of another family with so-called May-Hegglin anomaly. 
The inclusions consisted of clusters of ribosomes and small segments 
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of rough endoplasmic reticulum (RER), and lacked the parallel strands 
of RER seen in Dohle bodies. An explanation for this phenomenon could 
not be given and the authors coined a new syndrome: Fechtner syndrome, 
after the last name of the propositus. The occurrence of antithyroid 
antibodies in Alport's syndrome has been reported (Miyoshi et al., 
1975; Zeromski et al., 1976; Simon et al., 1977; Fujimoto et al., 
1980). Miyoshi et al reported one patient with hypothyroidism and one 
with chronic thyroiditis. 
The only other study available on thyroid and Alport's syndrome is 
that of Gayno and Savoie (1983), who observed in one family 6 cases of 
thyroid disorder including 5 obvious goiters. Three of their patients 
had symptoms of thyroid deficiency. In these 6 patients there were no 
antithyroid antibodies detectable. 
Various urinary abnormalities have been reported in Alport's 
syndrome. Hematuria, proteinuria, and, occasionally, prolinuria, were 
already mentioned. An increased excretion of the third component of 
complement and its catabolites was observed, but its meaning was 
unknown (Chiù and Atkin, 1983). Further studies revealed, that this 
phenomenon was present in 70% of 59 patients with Alport's syndrome, 
in contrast to 5й of 62 patients with other kidney diseases (Chiù and 
Atkin, 1985). 
Several studies have been performed on urinary collagen degradation 
products of the renal basement membranes. Tina et al. (1979) and 
Veltischev et al. (1983) observed an increased excretion of glucosyl-
galactosylhydroxylysine and galactosylhydroxylysine. The excretion of 
another amino acid, specific for basement membrane collagen i.e., 
3-hydroxyproline, has been reported to be normal (Grünfeld, 1985). 
Lubec et al. (1978) investigated urinary samples of Alport patients 
for glomerular basement membrane antigens, applying a rabbit anti-
glomerular basement membrane antibody. A typical antigen was found in 
the urine of 8 out of 12 children. It was not present in normal 
children nor in patients with idiopathic nephrotic syndrome. No other 
glomerulopathies, however, were included in this study. Affinity 
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chromatography using Goodpasture antiserum was performed on 
concentrated urine specimens of 15 patients (Lubec and Shabbir, 
1984). In 14 patients no antigen was bound, in contrast to positive 
findings in controls and patients with glomerulonephritis. These 
studies need to be confirmed by other groups. Finally, a significantly 
increased excretion of glycosaminoglyeans was observed in 12 Alport 
patients, compared to normals and patients with idiopathic nephrotic 
syndrome (Lubec et al., 19Θ0). No other kidney diseases, however, were 
studied. 
1.2.2. HISTOPATHOLOGY 
Light microscopic findings in renal tissue in Alport's syndrome are 
not characteristic. In early stages no abnormalities can be observed, 
and later a "mixed" nephritis develops with alternating areas of 
severe tubular atrophy and patchy glomerular involvement (Krickstein 
et al., 1966). Glomerular basement membrane thickening was described 
as the earliest and most common lesion (without the use of 
electronmicroscopy) by Krickstein et al. (1966) and Kaufman et al. 
(1970). The specificity of the presence of foam cells in the biopsy 
was extensively discussed, but these cells are now considered to be 
nonspecific for the disease (Whalen et al., 1961; Rosen et al., 1966; 
Neustein et al., 1972). 
Routine immunofluorescence investigation of the kidney biopsy 
reveals no specific abnormalities in Alport's syndrome (Spear et al., 
1970; O'Neill et al., 1980). Sometimes, scattered Сз-depositions may 
be present (Gubler et al., 1981), and, in advanced cases, focal 
deposits oflgM and/or C3 are abserved (Habib et al., 1982). 
With electronmicroscopy more specific lesions were established. The 
glomerular basement membrane is irregularly thickened with irregular 
inner and outer contours and with splitting of the lamina densa (Habib 
et al., 1982). Electrodense granulations are often, although not 
always, present within the lucent zones delineated by the thin 
interwoven layers of the lamina densa (Farboody et al., 1979). The 
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(non-)3pecificity of these lesions has been extensively discussed 
(Hinglais et al., 1972; Spear and Slusser, 1972; Churg and Sherman, 
1973; Hill et al., 1974; Rumpelt et al., 1974; Sessa et al., 1974; 
Sherman et al., 1974; Kohaut et al., 1976; Beathard and Granholm, 
1977). Extreme attenuation of the glomerular basement membrane is also 
observed (Rumpelt et al., 1974; Gubler et al., 1981). The importance 
of this finding and the confusion with benign hematuria is discussed 
in Chapter 5. 
The tubular basement membranes appear to be normal (Gaboardi et 
al., 1974), although similar lesions have been observed as in the 
glomerular basement membranes (Churg and Sherman, 1973). Recent 
investigations with a monoclonal antibody indicated an abnormal 
composition of the distal tubular basement membrane (Savage et al., 
1986a, Ь). This antibody gave a reduced or absent binding to the 
basement membranes of Alport patients. In the control groups a bright 
linear fluorescence was observed. 
The age at which the characteristic lesions develop, is unknown. 
Serial biopsies have seldomly been performed. The lesions were already 
found in young children (2-4 years of age; Habib et al., 1982). In one 
family glomerular basement membrane changes were absent in four 
affected siblings on a biopsy specimen obtained at 11-23 years and 
were present 8 years later on a repeat biopsy obtained in two of them 
(Beathard and Granholm, 1977). One patient showed diffuse thinning of 
the glomerular basement membrane at 12 years, and the same 
abnormality, without progression, at 25 years (Habib et al., 1982). 
Clinical findings were, however, fitting with Alport's syndrome. 
Rumpelt (1980) observed an increase in the splitting lesion with age 
in males, but not in females. A higher rate of basement membrane 
alterations corresponded with a more severe clinical course in his 
male patients. 
The abnormal structure of the basement membrane has led to 
speculations about the pathogenesis of the syndrome. As the glomerular 
basement membrane is largely composed of collagenous proteins, 
abnormal composition, synthesis and/or metabolism of these proteins 
have been supposed (Spear, 1973). These assumptions are supported by 
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recent biochemical studies. The glomerular basement membrane of Alport 
patients contained significantly less hydroxyproline, hydroxylysine 
and half-cystine than that of normals (Habib et al., 1982). In this 
study, endstage kidneys were investigated. In one patient a decrease 
of hydroxyproline and half-cystine content was observed, with normal 
hydroxylysine-content (DiBona, 1983). 
Immunological investigations contributed important new information 
in Alport's syndrome. Glomerular basement membranes of some Alport 
patients fail to bind anti-glomerular basement membrane serum from 
patients with Goodpasture syndrome (Olson et al., 1980; Jenis et al., 
1981; McCoy et al., 1982). In young children ( <3 years of age) also 
an absence of staining of the glomerular basement membrane with 
Goodpasture antiserum was observed (Anand et al., 1978). The 
Goodpasture antigen is part of the collagen IV molecule (Wieslander et 
al., 1984 a), and localized in the noncollagenous, globular domain 
(NC1) (Wieslander et al., 1984b; Butkowski et al., 1985). This domain 
is part of the connecting region of the collagen molecules and exists 
as a hexameг (М
г
 = 170,000) composed of monomeric and dimeric 
polypeptides. The Goodpasture antigen resides in monomer M2 and dimer 
O2. It is sequestered inside the hexamer but becomes exposed and binds 
with the Goodpasture antibody after denaturation (Wieslander et al., 
1985). This process proved to be reversible. Possibly hiding of the 
antigen is responsible for the absence of reactivity with Goodpasture 
antiserum in young infants and some Alport patients. With respect to 
the young infants this has been demonstrated by Yoshioka et al. 
(1985). Four out of 10 human anti-glomerular basement membrane 
antibodies, reactive with adult kidney tissue gave a positive reaction 
with fetal and infant kidney tissue on immunofluorescence, and six a 
negative one. After denaturation with 6 M urea infant and fetal kidney 
sections reacted with all antisera. Jeraj et al. (1983) also found 
variable staining in 5 kindreds with Alport's syndrome and concluded 
that absence of Goodpasture antigen leads to severe disease in males, 
while its presence relates to mild disease in females. The same 
authors always observed a normal staining of the glomerular basement 
membrane using monoclonal antibodies directed against the glomerular 
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basement membrane (Jeraj et al., 1983). This monoclonal antibody also 
stained fetal and infant glomeruli (Jeraj et al., 1984). Application 
ofanother monoclonal antibody, directed against the Goodpasture 
antigen, showed an absent (9 patients) or markedly reduced (3 
patients) binding to glomerular and tubular basement membranes in 
patients with Alport's syndrome compared to controls (Savage et al., 
19B6 a ) Ь). in 29 patients with hematuria, due to other renal diseases, 
a normal binding was found. These findings, however, have not yet been 
confirmed by other groups. Investigation of glomerular basement 
membrane with antisera against specific anti-glomerular basement 
membrane components did not show differences in stainability between 
normals and patients (Habib et al., 1982; Noël et al., 1985). Recently 
it was observed that with indirect immunofluorescence techniques 
amyloid Ρ was absent in the glomerular basement membranes of six 
Alport patients, as was the Goodpasture antigen (Melvin et al., 
1986). Both constituents were present in ten normal kidneys. 
Scarce reports have been published on the epidermal basement 
membrane in Alport's syndrome. Martinez-Hernandez and Amenta (1983) 
studied several members of one family with Alport's syndrome. Not only 
the renal, but also the epidermal and vascular basement membranes in 
the skin were multi-lamellated. Kashtan et al. (19Θ5) applied serum of 
an Alport patient, who developed anti-glomerular basement membrane 
nephritis in his renal allograft, to skin tissue of Alport patients. 
They observed a complete absence of the antigen in affected males and 
an incomplete one in affected females. All controls showed a bright 
linear fluorescence. 
1.2.3. GENETICS 
The genetics of Alport's syndrome have long been the subject of 
debate. The different prognosis in males and females suggests an 
X-linked inheritance, but the occasional occurrence of male-to-male 
transmission excludes this. Preus and Fraser (1971) reviewed the 
literature on available data and calculated the risk of developing the 
disease. If the mother was affected, the risk for daughters was 453! 
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and For sons 42'o, but iF the Father was aFFected, the risk For 
daughters was ЗЗ'о and For sons only ІЗ". They concluded to an 
autosomal dominant, sex-inFluenced disease, with a reduced penetrance 
in the sons oF aFFected Fathers. 
The latest edition oF McKusicks catalogue (1986) lists three modes 
oF inheritance: autosomal dominant (nr. 10420), autosomal recessive 
(nr. 2037B), and X-linked dominant (nr. 30105). The X-linked Form oF 
Alport's syndrome exists in large pedigrees From Salt Lake City 
(O'Neill et al., 1978; Hasstedt and Atkin, 1983). X-linked inheritance 
was recently conFirmed by Menlove et al. (1984, 1985), who showed 
linkage between X-chromosomal marker genes and the Alport's syndrome 
gene in Families From the same Mormon community. Possibly the Families 
studied were identical to those oF Hasstedt and Atkin (1983). The gene 
was localized on the long arm oF the X-chromosome. A localization in 
the centromenc region was suggested, based on linkage with probe DXS3 
(19-2) and probe 0XS1 (8EA). Lod scores* were 7.66 at theta = 0.22 and 
2.57 at theta = 0.25 respectively. The autosomal dominant Form is 
assumed For many series published, although the authors observe a less 
Frequent male-to-male transmission than expected (Feingold 4 Bois, 
1971; Shaw 4 Kallen, 1976; Kenya et al., 1977). The autosomal 
recessive Form has only recently been described in a Few Families 
(Gubler et al., 1981; Passwell et al., 1981; GrunFeld, 1985). All 
three modes were observed by Feingold et al. (1985). They conclude to 
a genetic heterogeneity oF the syndrome. This heterogeneity had been 
noted beFore (Evans et al., 1980). It impairs the determination oF the 
individual prognosis and genetic counselling. 
Ono et al. (1980) reported, in a Family with autosomal dominant 
Alport's syndrome, an interrelation with the HLA-Factors AW 31, BW 51 
and DW 1. Hashimoto et al. (1983) Found the Frequency oF HLA-DR 4 
signiFicantly higher in Alport patients than in controls. The genetic 
mode in these Families is, however, not reported. 
1.2.4. DATA FROM TRANSPLANTATION 
According to the ACS/NIH Organ Transplant Registry and the Registry 
* (log odds score: a lod score oF ü 2 is comparable with a 
sigmFicance oF ρ -0.01) 
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of the European Dialysis and Transplantation Association more than 100 
patients with Alport's syndrome have been treated with renal transplan-
tation (Groth and Ringden, 1984). Results of transplantation generally 
are described as good, although the development of antiglomerular 
basement membrane nephritis in the graft occasionally has been described 
(Wilson, 1980; Milliner et al., 1982; Kashtan et al., 1985) (Table III). 
Recurrence of the original disease also has been suggested (Mathew et 
al., 1975). It concerns one patient, who more probably had a chronic 
rejection in his allograft. In Alport's syndrome, the incidence of linear 
glomerular basement membrane fixation of IgG in the renal allograft is 
much higher than in other renal diseases (Quérin et al., 1986). Twelve 
out of 767 transplant recipients (34 Alport patients) developed linear 
fixation of IgG along the glomerular basement membrane. Among these 12 
patients, 5 had Alport's syndrome. The IgG-fixation was not clearly 
related to circulating anti-glomerular basement membrane antibodies and 
was not accompanied by significant deterioration of graft function. These 
findings can support, however, the idea of a deviating basement membrane 
antigen in this syndrome. 
Improvement of deafness after transplantation was reported by McDonald 
et al. (1978). More recently, it was reported not to be present (Jordan 
et al., 1984). 
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Table 1.3: Data on the development of anti-GBM-nephritis in the graft of 
Alport recipients. 
Sex Age at Graft Graft Circulating Graft 
transplan- donor survival anti-GBM pathology 
tation (months) antibodies 
(years) 
Wilson, 
19Θ0 
N.R. N.R. N.R. N.R. crescentic 
glomerulo­
nephritis 
with linear 
IgG of GBM 
fixation 
Milliner 
et al., 
19B2 
34 living 14 
rela­
ted 
rejection, 
crescentic 
glomerulo­
nephritis 
with linear 
IgG of GBM 
fixation 
N.R. = not reported. 
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1.4. AIM OF THE STUDIES 
For diagnosis of Alport's syndrome, the typical ultrastructural 
malformations have to be established. A renal biopsy has to be 
performed. Attempts have to be made to develop non-invasive methods. 
Investigation of blood or urinary specimina will be easier to perform, 
and might also be of use to detect symptomless carriers of the 
disease. Investigation of urine on basement membrane degradation 
products might be useful in this respect. Since the glycosides of 
hydroxylysine, glucosylgalactosylhydroxylysine and galactosylhydroxy-
lysine, theoretically are suitable markers of basement membrane 
degradation, we started to develop a method for analysis of these 
compounds in urine and established control values for different age 
groups (Chapter 2). Subsequently, patients suffering from Alport's 
syndrome and several other glomerulopathies were investigated (Chapter 
3). Since the peptide-bound hydroxylysylglycosides may be more 
basement membrane specific, these were assayed after alkaline 
hydrolysis of the urine (Chapter ή). 
Clinical and morphological differentiation between Alport's 
syndrome and benign familial hematuria appears to be rather 
difficult. Therefore we evaluated the renal biopsy material of the 
last 10 years and related the results to the clinical findings and the 
family history. Criteria for diagnosis and indications for kidney 
biopsy are presented (Chapter 5). 
Because of reports on association with the HLA-system in the 
literature, linkage- and association-studies have been performed 
(Chapter 6). The pedigrees in our material are compatible with 
X-linkage. Therefore, analysis of the X-chromosome has been performed 
on the three largest families (Chapter 7). 
In the Appendix the families of Alport patients who were involved 
in the investigations are described. 
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CHAPTER 2 
URINARY EXCRETION OF HYDROXYLYSINE AND ITS GLYCOSIDES IN NORMAL 
PERSONS OF DIFFERENT AGES - INFLUENCE OF MATURATION 
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2.1. ABSTRACT 
Basement membrane collagen is relatively rich in hydroxylysine and the 
glycosides of hydroxylysine, glucosylgalactosylhydroxylysine and ga-
lactosylhydroxylysine. In this paper a modified procedure for analysis 
of these substances in urine is described, using a punficationstep 
with the cation-exchange resin Amberlite CG-120 type II and a modified 
program for amino acid analysis. Values are obtained from 75 healthy 
persons of different ages ranging from prematurity to adulthood. The 
influence of maturation is studied. Prematures and young children have 
a high and rather variable excretion of all components, whereas adults 
have low and similar excretion rates. Neither the ratio glucosylgalac-
tosylhydroxylysine/galactosylhydroxylysine nor the percentage of gly-
cosylated hydroxylysine can be shown to be age-dependent. These data 
are important for the study of collagen disorders, especially in 
childhood. 
2.2 INTRODUCTION 
In the human body, collagen is a widespread constituent of connective 
tissue. Several types of collagen can be distinguished (1-3). One ty-
pe, collagen type IV, present in basement membranes, is characterized 
by a high content of glycosylated hydroxylysine and 3-hydroxyproline 
(3-5). The relative amount of these substances increases with age in 
glomerular and tubular basement membrane of men (6). Several procedu-
res have been described for the analysis of the glycosides of hydroxy-
lysine in urine (7-14). Most of these methods are complicated and 
time-consuming. The method described by Askenasi (10), a relativily 
simple technique, seems suitable for clinical practice. However inter-
ference of various acid and neutral amino acids seriously jeopardizes 
this method. We adapted the purification procedure of Isemura et al 
(15) to remove these substances. Assay of hydroxylysine and its glyco-
sides was performed with a modified amino acid analysis program. The 
method has been evaluated and applied for the analysis of 75 urine 
samples of healthy persons of different ages. Such a series of con-
trols can also be applied for evaluation of data of pathological ca-
ses, in which a matching of age and sex may be essential. 
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2.3. MATERIALS AND METHODS 
Urinary specimens 
From each of 75 healthy persons of different ages a 24 h urinary spe-
cimen was collected. Urine was preserved with NaN3. During the collec-
tion period the urine was kept at +4°C and within a few hours frozen 
at -70oC. 
Chemicals 
All chemicals used were of analytical grade. DL-allo-hydroxylysine was 
purchased from Koch-Light (Cohn Brook, Bucks, England), L-homoarginine 
from Nutritional Biochemicals Corporation (Cleveland, OH, USA). Gluco-
sylgalactosylhydroylysine and galactosylhydroxylysine were isolated 
from ocean sponge, using the method described by Smith (16), followed 
by high-voltage paper electrophoresis according to Moczar and Moczar 
(17) and desalting on Bio-Gel P-2 (100-200 mesh; BioRad Laboratories, 
Richmond, CA, USA) with 10 mM acetic acid as the eluent. The amount of 
glucosylgalactosylhydroxylysine and galactosylhydroxylysine was deter-
mined by amino acid and carbohydrateanalysis after hydrolysis in 2 M 
HCl for 2.5 h. at 100°C in sealed glass tubes (6). Amberlite CG 120 
(Na+) (type II, 200 mesh), was converted into the H+ form and washed 
until neutral. 
Methods 
A volume of 5 ml of centrifuged urine is acidified with 2 M HCl to 
pH2. Homoarginine (100 nmol) is added as a standard. The sample is 
added to 5 ml of Amberlite-resin (packed volume) in polypropylene 
tubes. After equilibration, repeated washing and elution is performed 
batchwise by mixing the tubes for 5 min, followed by centrifugation 
for 5 min and removal of supernatant. This treatment is carried out in 
the following sequence: thrice with water, seven times with 12% pyri-
dine and seven times with 5 M ammonium hydroxyde. The ammoniacal elua-
tes are collected and 100 nmol norleucine is added as an external 
standard for amino acid analysis. After evaporation to dryness the 
residue is dissolved in 3 ml of water. To remove residual ammonia pH 
is brought to 13 with 2 M NaOH and the sample placed under reduced 
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pressure above concentrated sulphuric acid for two days. Sequentially, 
the sanple is acidified to pH2 with 2 M HCl, evaporated and dissolved 
in 1 ml of 0.2 M lithium citrate buffer (pH 1.8). 
Amino acid analysis of 200 ul samples is performed using a Riotronik 
LC 6000 amino acid analyser with Durrum DC6A-resin. Elution is perfor-
med with two lithiumcitrate-buffers. The first buffer (0.35 M Li; pH 
3.43) has a run time of 41 min, the second one (1.4 M Li; pH 3.62) of 
110 min. A temperature change from 430-480C occurred after 21 min, and 
a second change (48°-75°C) after 61 min. The complete procedure of 
amino acid analysis, including regeneration and equilibration of the 
resin, takes about 4 h. 
Statistical calculations 
For comparison of preterm and young infants Student's t-test was 
used. For study of sex- and age-differences in the older groups one-
way and two-way analyses of variance were applied followed by pairwise 
multiple comparisons according to Scheffé. 
2.4. RESULTS AND DISCUSSION 
Purification of urine is necessary for the accurate determination of 
hydroxylysylglycosides. The choice of a suitable standard is complica-
ted by this purification step. Norleucine is almost completely removed 
by the purification. Hence, two standards are used for the analysis. 
Homoarginine is used for the control of recovery during the purifica-
tion procedure. Norleucine is added immediately after the purifica-
tion, and serves as an external standard for amino acid analysis. 
A chromatogram of a standard solution containing hydroxylysine, gluco-
sylgalactosylhydroxylysine and galactosylhydroxylysine is shown in 
Fig.1. The elution times of the different substances are 38 min for 
glucosylgalactosylhydroxylysine, 46 min for norleucine, 70 min for 
galactosylhydroxylysine, 89 min for hydroxylysine and 150 min for 
homoarginine. The ninhydrincolour yield, with respect to norleucine, 
amounts 88% for glucosylgalactosylhydroxylysine, 125Ж for galactosyl­
hydroxylysine and 114!o for hydroxylysine. Fig.2 shows the results of 
amino acid analysis of a purified urinary specimen. Most of the acid 
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Fig.2-1 Chromatogram of the standard solution, containing in 1 ml buf-
fer:40 nmol glucosylgalactosylhydroxylysine (GGH), 100 nmol norleucine 
(nor), 40 nmol galactosylhydraxylysine (GH), 40 nmol hydroxylysine 
(hyl) and 100 nmol homoarginine (homo). 
Fig.2-2 Chromatogram of a purified urinary specimen. 
Homorhomoarginine, hyl=hydroxylysine, GH=galactosyIhydroxylysine, 
normorleucine, GGH=glucosylgalactosylhydroxylysine. 
and neutral amino acids have been removed by the purification step. 
To ascertain that no other substances elute together with the glyco-
sides, 6 urine samples of healthy persons were analyzed before and 
after destruction of the glycosides by acid hydrolysis (4 h with 2 
M HCl at 100oC). After hydrolysis no ninhydrin-positive compounds co-
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Fig.2-3 Excretion of glycosyl-
galactosylhydroxylysine (a), 
galactosylhydroxylysine (b) 
and hydroxylysine (c), by 75 
healthy subjects of different 
ages. 
P=premature3 (32-36 weeks ge­
stational age). 
Adults=19-44 years. 
chrornatographed with the glycosides. 
To determine the recovery of both hydroxylysylglycosides and of 
hydroxylysine and homoarginine in urine, known amounts of these sub-
stances were added to urinary samples of different persons (3 adults, 
•J newborns). Recoveries of glucosylgalactosylhydroxylysine, galacto-
sylhydroxylysine, hydroxylysine and homoarginine amounted to 99±25ó, 
93±2Й, ñ2±U% and 72±4?S, respectively. The water and pyridine eluates 
did not contain any of these compounds in measurable quantities. Homo-
arginine-recovery is relatively low but constant. Possibly strong bin-
ding to the resin of this basic amino acid is responsible for this low 
recovery. Data given are based on amino acid analysis, in which homo-
arginine-recovery was at least 70%. Values were not corrected for 
recovery. 
To determine precision of the method, one adult urine was analyzed 
sixfold. The coefficient of variation of the glycoside concentration 
was 5.4X for glucosylgalactosylhydroxylysine and 6.6% for galactosyl-
hydroxylysine. In each series of analyses of 11 urine samples always a 
standard solution is similarly treated as control. Fig.3 shows the 
distribution of the measured compounds for the individual urine sam-
ples as a function of age. The high and variable excretion of all 
studied substances in prematures and young infants is remarkable. In 
adults the excretion is much lower and within a smaller range. The 
high excretion in the young age groups is partly due to a low creati-
nine-excretion. The same picture -though less obvious- is obtained 
when values are expressed in ymol/24 h per 1.73 m^. Means and standard 
deviations for different age groups are given in table 1. For adults 
the values of urinary excretion observed are comparable to those of 
other authors (Table 2). 
In infants and children, urinary excretion has not extensively been 
studied, though some authors mention higher excretion rate as compared 
with adults (8,12,18). This is explained by the higher collagen 
turnover at younger age. Preterm infants excrete more glycosides than 
young infants with an age of 0-12 months, when the concentrations are 
expressed in цтоі/д créât (p=0.01 for galactosylhydroxylysine; p=0.002 
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Prematures 
0 12 months 
1 2 years 
3 11 years 
12 17 years 
Adults 
(19 4 4 y e a r s | 
(Bl 
(16) 
(8) 
(19) 
(10) 
(14) 
GGH 
230 + 73 
1 2 1 + 7 2 
5 1 + 2 2 
33 + 15 
30 + 14 
1 3 + 3 
и
т о І / д créât 
GH 
159 + 53 
101 +45 
4 2 * 18 
24+ e 
2 0 - 7 
9 + 2 
HyL 
131 + 8 9 
103 + 63 
25 + 17 
11 t 4 
9 + 5 
4 + 2 
GGH 
5 0 ' 17 
36 + 22 
2 4 + 1 1 
24+ 9 
2 6 + 1 5 
1 6 * 4 
и т о І / 2 4 h 1 73 т г 
GH 
35 + 13 
30 + 13 
1 9 + 8 
17 · 5 
1 8 * 7 
1 1 + 3 
Hyl 
30 + 22 
31 ι 17 
1 1 * 7 
8 + 3 
8 + 3 
5 ' 2 
Ratio 
GGH/GH 
1 4 6 * 0 14 
1 1 7 * 0 51 
1 24 * 0 21 
1 36 * 0 23 
1 6 8 * 1 15 
1 50 * 0 28 
%glycosylated 
hydroxylysine 
76 9 + 8 5 
6 8 0 + 1 4 3 
79 9 + 6 6 
83 7 » 5 4 
8 4 5 * 5 4 
83 9 * 4 3 
Values are means + SD The numbers of individuals are given vwithm parentheses 
Table 2-1: Excretion of hydroxylysine and its glycosides in different 
age groups. 
for glucosylgalactosylhydroxylysine). For hydroxylysine no differences 
are seen (p=0.39). When the concentrations are expressed per body 
surface no significant differences are found for each compound (p> 
0.10). The low creatinme-excretion in these prematures accounts for 
this discrepancy. 
GGH GH Hyl GGH/GH 
Askenasi (10) 
Kakimoto (7) 
This series 
11 16.5±1.8 
13 20.8±8.9 
14 12.6±3.2 
11.0±2.7 
12.2*5.2 
B.6±2.3 
8.6±2.5 
9.0±4.5 
4.1*1.7 
1.55*0.40 
1.75*0.54 
1.50*0.28 
Table 2-2: Comparison of excretion of hydroxylysine and its glycosides 
in healthy adult persons as described in literature with data obtained 
in this study. 
(concentration in ymol/g.creat. ; mean * ^3"' 
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1 2 years 3-11 years 12-17 years Adult Testing results 
Male Female Male Female Male Female Male Female 
И) И) (10) (9) (5) (5) (6) (в) Р
д
. P s Ρ, 
GGH 
μπιοΙ/9 creai 
Mmol/24 h 1 73 m ¡ 
ц т о і / д creai 
ц т о І / 2 4 h 1 73 m 1 
Hyl 
ц т о і / д créât 
μπιοΙ/24 h 1 73 m' 
5 5 1 3 2 
27 1 1 4 
4 0 1 2 4 
1 9 l 10 
27 1 2 3 
1 3 * В 
47 1 1 1 
21 t β 
4 3 1 1 3 
1 9 + β 
22 1 1 2 
1 0 * 7 
3 8 * 1 9 
2 6 l 10 
2 6 1 1 0 
l e i 6 
1 0 * 5 
7 1 3 
2 8 * 8 
21 1 7 
22 1 5 
І б і б 
12 + 4 
9 t 4 
30 + 6 
28 1 5 
2 5 * 7 
23 + 5 
1 1 * 6 
1 0 í 3 
30 1 2 0 
2 8 * 2 2 
14 1 2 
13 + 3 
7 1 3 
6 1 4 
14 1 3 
1 8 1 4 
9 1 1 
1 2 1 2 
5 1 2 
6 î 2 
1 2 1 4 
14 14 
В і З 
10 1 4 
4 * 2 
5 і 2 
•^0 001 
0 02 
< 0 0О1 
' 0 001 
< 0 0О1 
0 01 
0 1 7 
0 0 6 
0 09 
0 02 
0 33 
0 1 3 
0 9 0 
1 00 
0 1 5 
0 19 
0 35 
0 19 
Values are means * SD The numbers of individuals are given within parentheses The ρ values PA, Ps and PAS are respectively the testing results 
as obtained by testing the hypotheses of no age effect, no sex effect and of no interaction between age and sex according to a two-way analysis 
of variance with respect to the logarithmic transformed data 
Table 2-3: Effect of sex on the excretion of hydroxylysylglycosides 
and hydroxylyaine. 
Concerning the older age groups both the effects of age and sex have 
been examined with respect to glucosylgalactosylhydroxylysine, galac-
tosylhydroxylysine and hydroxylysine. The means and standard devia­
tions of the subgroups classified according to both factors are given 
in table 3. We observe a decreasing variation of the excretion with 
decreasing rates. A logarithmic transformation of the data has been 
applied in order to stabilize the variances of the different sub­
groups. Two-way analysis of variance with respect to the transformed 
data give the testing results (p-values) as presented in the last 
columns of table 3. Clear age-dependent differences are found. Accor­
ding to the interaction tests it cannot be shown that these differen­
ces depend on sex. A further analysis of the age effects has been 
carried out by applying the Scheffé method of pairwise multiple compa-
risons. With respect to the concentrations expressed in ymol/g creati-
nine, each age group differs significantly from another age group (p 
sQ.05) with the exception of the 3-11 years old children versus the 
12-17 years old children (p>0.10). When the concentrations are expres-
sed per 1.73 m2 body surface no differences between the separate 
groups of children can be established. With respect to glucosylgalac-
tosylhydroxylysine the adults differ nearly significantly from the 
3-11 years old children (p=0.08) and significantly from the 12-17 
years old children. With respect to galactosylhydroxylysine the adults 
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Fig.2-4 Ratio of glucosylgalactosylhydroxylysine (GGH) and galactosyl-
hydroxylysine (GH) in urine of 75 healthy subjects of different ages. 
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Fig.2-5 Percentage glycosylated hydroxylysine in urine of 75 healthy 
subjects of different age. 
differ significantly from each of the three groups of children (p 
SO.02) and with respect to hydroxylysine from the 1-2 years old chil-
dren (p=0.02). 
As to the effect of sex, generally there are no significant differen-
ces. Males excrete significantly more galactosylhydroxylysine, when 
expressed in umol/24 h 1.73 m2. Askenasi (IB) did not observe sex dif-
ferences. 
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The ratio of glucosylgalactosylhydroxylysine to galactosylhydroxylysi-
ne (Fig.4) and the percentage of glycosylated hydroxylysine (Fig.5) do 
not show age-dependent differences, although some children have a low 
ratio. This is established by one-way analyses of variance. The hypo-
thesis of equal means for the four older age groups with respect to 
glucosylgalactosylhydroxylysine/galactosylhydroxylysine and the per-
centage of glycosylated hydroxylysine cannot be rejected (resp p=0.33 
and p=0.27; see also table 1). Urinary glycosides can originate from 
all types of collagen and the complement factor Clq. Increased excre-
tion in processes damaging bone or skin collagen has been reported 
(8,9,12,19,20). In normal persons the contribution of the renal base-
ment membrane to urinary glycosideexcretion is probably limited. In 
vitro perfusion of the isolated kidney allows the measurement of hy-
droxylysylglycosides independently of the amount of interstitial col-
lagen present in the body. Normally, kidney parenchyma contributes to 
less than 10% of glycosylated hydroxylysine in the urine (21). It is 
interesting to study the excretion of the glycosides in different con-
genital disorders of the renal basement membrane, as has been done by 
Tina et al (22) and recently, by Veltischev et al (23). The normal va-
lues at various ages, obtained in this study, permit the investigation 
of glycoside-excretion in collagen disorders in childhood. 
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3.1. ABSTRACT 
Alport's syndrome probably is a molecular disorder of basement mem-
brane composition. Investigation of urine on basement membrane compo-
nents such as hydroxylysine and its glycosides, glucosylgalactosyl-
hydroxylysine and galactosylhydroxylysine, may be helpful for diagno-
sis of the disease. 
Urinary specimens of 33 patients and 12 siblings were investigated, 
and the results were compared with those of 14 healthy adults and of 
29 healthy children. Urine of patients with other glomerulopathies, 
occurring during childhood (IgA-nephropathy, benign recurrent hematu-
ria, poststreptococcal glomerulonephritis, Henoch-Schönlein nephro-
pathy, membranoproliferative glomerulonephritis and nephrotic syndrome 
due to minimal lesions) was also investigated. No marked differences 
between normal and diseased subjects could be demonstrated, with res-
pect to excretion of hydroxylysine and its glycosides, in contrast to 
data reported in literature. 
3.2. INTRODUCTION 
Alport's syndrome is a hereditary disorder characterized by typical 
malformations of the glomerular basement membrane, observed in elec-
tronmicroscopy (1). In this disease a molecular defect of the glomeru-
lar basement membrane composition is assumed. As collagen type IV, 
present in glomerular basement membrane, is relatively rich in glyco-
sylated hydroxylysine (Hyl) (2) , compared to other collagen types, 
urinary excretion of the hydroxylysylglycosides, glucosylgalactosyl-
hydroxylysine (GGH) and galactosylhydroxylysine (GH), might be altered 
in this disease and might form a tool in diagnosis. Increased excre-
tion of these compounds has been reported (3,4 ) . 
For comparison the urinary excretion of Hyl and its glycosides was 
also investigated in diseases, which could present themselves with 
isolated hematuria and should be distinguished from Alport's syndrome, 
such as IgA-nephropathy and benign recurrent hematuria ( 5 ) , and in 
some other frequently occurring glomerular diseases. 
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3.3. METHODS 
Urinary specimens 
24 h specimens were collected and preserved with NaN3. During the col­
lection period the urine was kept at 44°C and within a few hours 
frozen at -70°C. 
Purification and analysis of urinary specimens 
The method has been described elsewhere in more detail (6). Briefly, 5 
ml of urine is acidified with 2M HCl to pH 2 and added to 5 ml (packed 
volume) of Amberlite CG 120 H + resin. Elution is performed subseguent-
ly with water, 125S pyridine and 5 M ammoniumhydroxide. The latter 
eluate is collected and evaporated to dryness. After removal of ammo­
nia the residue is dissolved in 1 ml of 0.2 M lithiumcitrate buffer 
(pH 1.8). Amino acid analysis is performed using a Biotronik LC 6000 
amino acid analyzer with Durrum DC 6A-resin. 
Patients 
Control subjects were 14 healthy adults and 29 healthy children. 33 
patients from 13 different families with Alport's syndrome were inves­
tigated. The diagnosis of Alport's syndrome was accepted when the 
typical electronmicroscopic alterations were present in the renal 
biopsy specimen of at least one member of the family, as well as a 
family history of renal insufficiency. In most families deafness was 
also present. The ultrastructural lesions consisted of diffuse or 
focal thickening and splitting of the glomerular basement membrane. 
The irregular alternation of thick, thin and normal glomerular base­
ment membrane was present. Urine was also collected from 12 siblings 
of patients, who appeared healthy. They had a normal hearing test. 
The θ patients, suffering from IgA-nephropathy, had hematuria, but 
otherwise a normal renal function. 
IgA-deposits were present in the mesangium of the glomeruli. Benign 
recurrent hematuria was diagnosed in 11 patients. All had hematuria, a 
normal glomerular function and on electronmicroscopy thin basement 
membranes. Renal insufficiency was not present in these families. 
Henoch-Schbnlein nephritis (5 cases) was characterized by the typical 
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skin lesions, hematuria with impairment of renal function and mostly 
focal proliferative lesions in the glomerulus. Acute poststreptococcal 
glomerulonephritis (7 cases) was characterized by hematuria, impair-
ment of glomerular filtration, increased antistreptolysin titer and 
decreased C3 in serum. All 6 cases of membranoproliferative glomerulo-
nephritis were of type I disease. The 9 patients with nephrotic syn-
drome showed minimal lesions. 
Statistical calculations 
The data have been classified into subgroups according to age class 
(3-11 years, 12-17 years, al8 years), sex and disease. Logarithmic 
transformation has been applied in order to stabilize the variances 
for the different subgroups. Differences between normal subjects, 
Alport patients and their siblings have been studied, averaged over 
both sexes and all age classes. Three multiple comparisons between 
subgroups have been made by using t-tests and introducing p=0.017 as a 
level of significance and p=0.033 as a level of nearly significance 
according to Bonferroni's principle. 
Differences between the other pathologic groups with normal subjects 
and Alport patients could only properly be examined for the lower age 
classes. Twelve multiple comparisons between subgroups have been made 
again by means of t-tests and using p=0.0042 as a level of signifi-
cance and p=0.0083 as a level of nearly significance. 
3.4. RESULTS 
The urinary excretion of GGH, GH and Hyl, the ratio GGH/GH, and the 
percentage of glycosylated Hyl in Alport patients and their siblings 
are shown in Table 1, compared to data obtained in normal subjects. 
The results for other patients are presented in Table 2. Excretory 
rates are summarized in the figures 1 and 2. 
The previously observed age- and sex-dependence of the urinary excre-
tion of the investigated compounds has been taken into account in the 
statistical analysis (6). 
Firstly the linear hypothesis, that averaged over the six subgroups 
(Table 1) the mean for Alport patients is equal to the mean for nor-
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Age Sex η G G H · G H ' HYL· G G H " G H b HYV Ratio % glycosylated 
yedPi G G H / G H hydroxylysine 
Normal subjects 
3-11 
12 17 
Adult 
Alport patients 
3-11 
12-17 
Adults 
Alport siblings 
3-11 
12 17 
Adult 
* Micromoles 
9 
<s 
9 
9 
d 
9 
<S 
9 
d 
9 
9 
d 
9 
d 
9 
10 
9 
5 
5 
6 
8 
4 
5 
3 
4 
4 
3 
2 
3 
3 
2 
2 
per gram creatinine, 
38 + 19 
28±8 
30±6 
30 ±20 
I4±3 
12±1 
42+15 
26±5 
28±8 
26±7 
11±4 
18±7 
40±3 
24 + 6 
21±5 
18±3 
I4±2 
26±10 
22±5 
25±7 
I4±2 
9±1 
8±3 
34±8 
22±4 
20±8 
18±7 
8±3 
10±3 
33±4 
19±7 
14±2 
11±1 
8 ± l 
'micromoles per 24 h 
10 + 5 
I2±4 
l l ± 6 
7±3 
5±2 
4 ± 2 
13±6 
6 ± 2 
5±3 
7±2 
2 ± l 
4 ± 3 
12±6 
I0±l 
6±1 
4 ± 0 
2 ± 0 
per 1 73 m! 
26±10 
20±7 
28±5 
28 ±22 
I8±4 
14±4 
32±12 
23±5 
38±9 
26±6 
13±5 
I8±5 
34±7 
27 ±12 
24±3 
23 ±1 
I7±4 
18±6 
I6±4 
23±5 
I3±3 
12±2 
10±4 
26±7 
19 + 4 
27±9 
17±3 
I0±3 
10±2 
27±5 
2 2 ± l l 
17±1 
I4±4 
9 ± 2 
7 ± 3 
9 ± 4 
10±3 
6 ± 3 
6 ± 2 
5 ± 2 
10±4 
6 ± 3 
7 ± 3 
7±1 
3 ± 2 
4 ± 3 
11±8 
10±2 
7 + 2 
4 ± 1 
2 ± 0 
145±0 24 
1 26±0 20 
1 2 3 ± 0 I 2 
2 14±1 57 
I52±034 
148±0 24 
1 22±0 25 
1 19±013 
144±0 17 
1 56±0 39 
I 4 2 ± 0 3 7 
177±045 
1 23 ± 0 03 
1 34±0 21 
1 46±0 11 
172 + 0 52 
1 8I±008 
86 0 ± 5 3 
82 3 ± 6 7 
8 3 4 ± 3 7 
85 1 ± 7 1 
8 3 5 ± 4 2 
8 4 2 ± 4 7 
8 5 9 ± 2 5 
8 9 0 ± 3 9 
91 0 ± 2 5 
8 5 7 ± 2 4 
9 0 5 ± 3 6 
8 6 9 ± 6 0 
859±7.l 
8 I 0 ± 5 9 
8 5 3 ± 3 9 
89 1 ± 0 6 
9 I 7 ± I 1 
Table 3-1: Excretion of hydroxylysine and its glycosides in normal 
subjects, patients suffering from Alport's syndrome And their healthy 
siblings, divided in age- and sex-subgroups. The ratio of glucosyl-
galactosylhydr oxylysine to galactosylhydroxylyaine and the percentage 
glycosylated hydroxylysine are also presented. Values are means ±50. 
mals, has been tested. Analogously the Alport siblings have been com­
pared with the normals and the Alport patients averaged over five sub­
groups; these comparisons did not involve the subgroups of the 3-11 
years old boys. Alport patients excrete less Hyl than normals (pr 
0.004) when concentrations are expressed in ymol/g creatinine, but for 
the other substances excreted no significant differences can be esta­
blished. When urinary concentrations are expressed in umol/24h.l.73m2 
no significant difference is found for any compound investigated. 
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Age Se« η GGH» GH' HYL» GGH* GHb HYLb Ratio % glycosylated 
years GGH/GH hydroxylysine 
Benign recurren! hematuria 
3-11 a 1 22 16 8 14 10 5 139 82 7 
9 5 35±I4 2 9 ± l l 14±5 25±9 20±5 11±6 I23±024 816±44 
12-17 d 4 27±14 25±I4 10±4 26±8 23±8 10±2 I15±008 8 2 8 ± 3 4 
9 I 43 36 21 27 22 13 1 20 79 1 
IgA nephropathy 
3-11 d I 28 26 14 26 25 14 106 79 1 
5 3 21±12 18±11 10±7 21±5 18±5 I0±3 1 20±0 13 7 9 9 ± 3 1 
12-17 d 3 24±9 I9±9 6 ± 4 25±14 20±12 7 ± 5 136±022 8 8 7 ± 4 0 
9 I 8 3 4 16 7 8 2 30 74 3 
Henoch-Schonlem nephritis 
3-11 d 3 29±I 25±4 I2±4 22±4 18±l 8 ± 3 121±017 8 2 6 ± 3 8 
9 2 25±12 22±I3 I0±4 18±7 16±8 7 ± 2 I I6±0 13 8 1 8 ± 2 5 
Acute glomerulonephritis 
3-11 d 5 33±10 30±6 12±6 2I±I0 I9±6 7 ± 4 110 + 024 8 4 4 ± 6 I 
12-17 d 2 33±6 29±9 11±1 28±9 24±4 9+1 I25±059 8 4 8 ± 0 0 
Membranoprohferaltve glomerulonephritis 
3-11 d 2 16±0 15±3 8 ± 3 20±6 19±3 9 ± 0 I 06±0 16 8 1 0 ± 4 3 
9 2 29±1 41±19 20±1 23±14 27±4 I5±8 0 8 0 ± 0 3 9 7 7 0 ± 3 5 
12-17 d 2 32±I8 24±12 6±1 35±22 26±1S 7 ± 2 I33±009 889±3.5 
Nephrotic syndrome 
3-11 d 1 27 22 9 25 20 8 122 85 5 
9 2 22±11 25±2 9 ± 7 14±3 I7±3 6 ± 3 088±037 9 2 7 ± 3 7 
12-17 d 6 21±8 17±6 7 ± 4 25±5 I8±5 8 ± 4 140±023 8 4 5 ± 6 7 
Micromoles per gram creatinine, binicromoles per 24 h per 1 73 m2 
Table 3-2: Excretion of hydroxylysine and its glycosides in patients 
suffering from benign recurrent hematuria, IgA-nephropathy, acute 
glomerulonephritis, membranoproliferative glomerulonephritis, minimal 
lesion nephrotic syndrome and Henoch-Schönlein-nephritis, divided in 
age- and sex-groups. The ratio of glucosylgalactosylhydroxylysine to 
galactosylhydroxylysine and the percentage glycosylated hydroxylysine 
are also presented. Values are means ±SD. 
Secondly the other patient groups are compared to normal persons and 
to Alport patients. Because of the fact that there are no adult pa-
tients for these groups only the age-groups 3-11 and 12-17 years have 
been involved. Further it can be seen from Table 2 that different sub-
groups are missing. For each of these patient groups the linear hypo-
thesis that averaged over the non-missing subgroups the mean is equal 
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to the corresponding mean (i.e. averaged over the same subgroups) of 
the normals e.g. Alport patients, has been tested. 
tïi.1 
normal 
children 
N-29 
(19 44y) (20 61 y) (3 17y) (3 17y) (5 17y) 
Fig. 3-1: Excretion of hydroxylysine and its glycosides in normal 
subjects, patients suffering from Alport's syndrome and their healthy 
siblings. 
jumol / g c réâ t 
5 0 -ι 
n o r m a l ben гее IgA Henoch MPGN nephr a c u t e 
children hematuria nephrop. Schonlem syndr GN 
N 29 N 11 N-θ N-5 N 6 N-9 N-7 
(3 17y) (3 14y) (5 15y) (6 11y) (5 15y) (3 17y) (5 15y) 
Fig.3-2: Excretion of hydroxylysine and its glycosides in normal 
children, and children suffering from benign recurrent hematuria, 
IgA -nephropathy, Henoch-Schonlein-nephntis, membranoproliferative 
glomerulonephritis, minimal lesion nephrotic syndrome and acute 
glomerulonephritis. 
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Patients suffering from IgA-nephropathy excrete significantly less GH 
than normal persons (p=0.001B) and Alport patients (p=0.0013) when 
expressed in ymol/g creatinine. With respect to GGH ( umol/g 
creatinine) there is also a significantly decreased excretion compared 
to normal persons (p=0.0023), and a nearly significantly lower 
excretion compared to Alport patients (p=0.0051). When concentrations 
are expressed in ymol/24 h 1.73m2 no significant differences can be 
observed. The other patient-groups studied do not differ significantly 
from the normal subjects or the Alport patients. 
3.5. DISCUSSION 
There are several indications that Alport's syndrome is caused by a 
molecular defect in basement membrane composition. A decrease in 
hydroxyproline, hydroxylysine and cystine content was demonstrated in 
isolated basement membranes of glomeruli of Alport patients (7,9) . 
Glomerular basement membranes of some Alport patients fail to bind 
anti-glomerular basement membrane serum ( 9-12), as do young childeren 
(13) . This finding could suggest a maturation defect, although others 
have contradicted the absence of Goodpasture-antigen in young children 
(14) . In urine, an increased excretion of hydroxylysylglycosides has 
been reported (3,4) . In the present study of a considerably larger 
patientgroup we were unable to confirm these findings. Other urinary 
abnormalities have been reported. Immuno-electrophoresis of urine of 
Alport patients revealed a glomerular basement membrane antigen, not 
present in controls, when an antiglomerular basement membrane antibody 
derived from rabbit was used (15). Others demonstrated catabolites of 
Сз in urine of Alport patients, not present in the urine of most other 
glomerulonephritic patients (16). Although still not proven, the hypo­
thesis of a molecular defect of the glomerular basement membrane re­
mains valid. Based on this defect the electronmicroscopic picture of 
the glomerular basement membrane, the multi-organ presentation (kid­
ney, ear, eye) and the genetic features can be explained. 
A number of renal diseases in childhood mimic Alport's syndrome in 
their clinical presentation. Among these, IgA-nephropathy and benign 
recurrent hematuria are the most important ones. In benign recurrent 
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hematuria a normal excretion of hydroxylysylglycosides was measured. 
In IgA-nephropathy excretion of glycosides appears to be diminished, 
when concentrations are expressed in umol/g creatinine. In the other 
glomerulopathies studied no abnormal excretion could be established. 
The tubular handling of Hyl and its glycosides was not investigated in 
this study. 
An increased excretion of hydroxylysylglycosides has been reported in 
a number of collagen disorders, such as Paget's disease (17-21). With 
respect to renal diseases only two studies are available ( 3,4). Our 
normal values for adults correspond well to those reported in litera-
ture (22,23). For children, reference data were presented in a former 
study (6). Children have a higher excretion rate compared to adults, 
because of a higher collagen turnover. 
It is possible that an abnormal composition of basement membrane is 
not reflected in urine. As the kidney parenchyma of dogs contributes 
no more than 10JÍ of the glycosylated Hyl excreted in urine ( 24) , the 
excretion of these glycosides might be a minor reflection of an abnor-
mality in the glomerular basement membrane. Investigation of the pep-
tide-bound fraction of urinary glycosides, which appears to be more 
basement membrane-collagen specific because of a higher ratio between 
GGH and GH, as compared to the free glycosides (25), may be a better 
approach to diagnosis of renal basement membrane disorders. 
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4.1. ABSTRACT 
Аз Alport's syndrome probably is a molecular disorder of basement mem­
brane composition, investigation of the urine on basement membrane 
components might be a diagnostic aid. Previously, it was shown that 
measurement of the excretion of free hydroxylysine and its glycosides, 
glucosylgalactosylhydroxylysine and galactosylhydroxylysine, was not 
useful for this purpose. Because the urinary peptide-bound fraction 
may be more basement membrane specific, a subsequent study was perfor­
med with respect to the total (=free and peptide-bound) concentrations 
and fractions. To establish reference values, urinary specimens of 38 
normal subjects of different ages were investigated. These values were 
used for comparison with data on 30 Alport patients, 10 Alport sib­
lings, and 33 patients suffering from other glomerular diseases. No 
marked differences were observed in the excretory rates between nor­
mals and patients. 
4.2. INTRODUCTION 
Basement membrane collagen type IV is relatively rich in glycosylated 
hydroxylysine, compared to the other collagen types (1). In diseases, 
in which a molecular defect in glomerular basement membrane composi­
tion із assumed, such аз Alport's syndrome, an altered excretion of 
the glycosides of hydroxylysine, glucosylgalactosylhydroxylysine (GGH) 
and galactosylhydroxylysine (GH), can be expected. Increased excretion 
rates of GGH and GH have been reported in this syndrome (2,3). In a 
former study, however, we were unable to distinguish clearly Alport 
patients and patients with other glomerulopathies from normals (4,5). 
The investigation of peptide-bound hydroxylysylglycosides might be a 
more promising approach from a diagnostic point of view. In nephro­
toxic serum nephritis in the rat, an increased urinary excretion, 
mainly of these peptide-bound glycosides, was observed (6). In this 
fraction a high GGH/GH ratio, resembling more the ratio of the base­
ment membrane collagen, is present. 
The aim of the present study is the investigation of total i.e., free 
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plus peptide-bound hydroxylysine and its glycosides in normal controls 
of different ages, in Alport patients and their siblings, and in 
patients suffering from other glomerulopathies. The data are related 
to the previous results on the free hydroxylysylglycosides, to evalu-
ate the possible significance of the peptide-bound fraction as a diag-
nostic aid. 
4.3. PATIENTS AND METHODS 
Patients 
Control subjects were 12 healthy adults (20-44 years) and 26 healthy 
children (6-17 years). 30 patients from 13 different families with 
Alport's syndrome were investigated. Family histories were positive 
for renal insufficiency and, mostly, for deafness. Renal biopsy was 
performed in at least one member of the family and showed the typical 
ultrastructural lesions: feuilleté-aspect of the glomerular basement 
membrane with irregular thickening and splitting, and the presence of 
granules. The criterion for inclusion in the study of the other 
patients of these families was the presence of hematuria. Ten appa-
rently healthy siblings of the patients were also investigated. They 
had a normal serum creatinine, a normal urinary sediment, and a normal 
hearing test. The 5 patients suffering from IgA-nephropathy had hema-
turia, but otherwise a normal renal function. IgA-deposits were pre-
sent in the mesangium of the glomeruli. The 10 patients with benign 
recurrent hematuria showed a normal glomerular filtration rate and 
thin basement membranes in the biopsy specimen. The family history of 
these patients was negative for renal insufficiency. Henoch Schönlein 
nephritis (5 cases) was characterized by the typical skin lesions, 
hematuria with impairment of renal function and mostly focal prolife-
rative lesions in the glomerulus. All 4 cases of membranoproliferative 
glomerulonephritis were of type I disease. Acute poststreptococcal 
glomerulonephritis (3 cases) was characterized by hematuria, impair-
ment of glomerular filtration, increased antistreptolysin titer, and 
decreased C3 in serum. The 6 patients with nephrotic syndrome showed 
minimal lesions. 
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Purification and analysis of urinary specimens. 
From all subjects 24h urinary specimens were collected and preserved 
with NaN3. During the collection period the urine was kept at +40C and 
within a few hours frozen at -70°C. When the urine specimen contained 
more than 0.5 q/1 of protein, it was treated on an Amicon PM 10 fil­
ter. 
Analyses are performed in duplicate. Hydroxylysine (80 nmol) is added 
to one of each pair of samples as a standard. A volume of 2.5 ml of 5 
M КОН is added to an equal volume of urine in a Pyrex-tube. These mix­
tures are frozen in a C02-3cetone mixture under nitrogen, and subse­
quently tubes are sealed in vacuo. After hydrolysis (20h;110oC) the 
samples are neutralized with 70% HCIO4. After centrifuqation for 10 
min the pellet is washed thrice with water. All supernatants are col­
lected, acidified to pH 2 with 2 M HCl, and added to 5 ml (packed 
volume) of Amberlite CG 120 H + resin. The elution procedure and amino 
acid analysis were described previously (4). Briefly, elution is per­
formed subsequently with water, 12л pyridine and 5 M ammonia. The lat­
ter eluate is collected and evaporated to dryness. After removal of 
ammonia the residue is dissolved in 1 ml of 0.2 M lithium citrate buf­
fer (pH 1.8). Amino acid analysis is performed using a Biotronik LC 
6000 amino acid analyser with Durrum DC6A-resin. 
Statistical calculations 
For study of sex- and age-differences in the normal subjects two-way 
analyses of variance were performed followed by pairwise multiple com­
parisons according to Scheffé. Logarithmic transformation of the data 
was applied for a part of the variables in order to stabilize the 
variances of the different subgroups. 
Differences between normal subjects, Alport patients, and their sib-
lings were studied, averaged over both sexes and the age classes (6-11 
years, 12-17 years and al8 years). Three multiple comparisons between 
subgroups were made using t-tests and introducing p=0.017 as a level 
for significance and p=0.033 as a level of nearly significance accor-
ding to Bonferroni's principle. 
Concerning the differences between the other pathologic groups with 
both normal subjects and Alport patients twelve multiple comparisons 
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between subgroups were made by means of t-tests and using p=0.00A2 as 
a level of significance and p=0.0083 as a level of nearly 
significance. Only the age classes 6-11 years and 12-17 years were 
involved in this examination. 
4.4. RESULTS 
Recovery of the hydroxylysine added to one of each pair of 
urinesamples was 81.6±7.0% (mean±SD). If the recovery was below 70% 
analysis was repeated. The recovery of GGH, added to the urine of 7 
adult persons was 76.8±10.2й. To determine the precision of the 
method, one urine was analyzed ninefold. The coefficient of variation 
was 5.5!o for GGH and 4.65S for GH. The influence of hydrolysis time was 
investigated by hydrolysis of 3 urine samples in fourfold for 20 and 
44h. Prolonged hydrolysis during 44h did not result in an increased 
concentration of any compound. In each series of analyses of 12 urine 
samples (six patients in duplicate, with and without hydroxylysine 
standard added) always a standard solution was similarly treated and 
analyzed. 
Concentrations of total hydroxylysine and its glycosides, expressed 
both in jumol/g creat and /umol/24h 1.73 m2, and corrected for the 
hydroxylysine-recovery are shown in Tables 1 and 2. Additionally, the 
GGH/GH-ratio, the percentage of glycosylated hydroxylysine and the 
percentages of the excreted free compounds of the total concentrations 
are presented. The latter percentages could be determined in 32 out of 
38 normal subjects and in 6Θ out of 73 patients. 
For the normal subjects both the effect of age and sex was examined 
with respect to each of the above mentioned variables. Two-way 
analyses of variance with respect to the transformed data give the 
testing results (p-values) as presented in the last columns of Table 
I. For most variables clear age differences are found. According to 
the interaction tests these differences do not depend on sex 
significantly. A further analysis of the age effects was carried out 
by applying the Scheffé-method for pairwise multiple comparisons. 
There are no significant differences between the 6-11 years and 12-17 
years old children (pa0.11). When the concentrations are expressed in 
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to 
GGH 
μmol/g créât 
/umol/24h 1.73m2 
GH 
/umol/g creat 
AJrnol/24h 1.73m2 
Hyl 
/umol/g creat 
/umol/24h 1.73m2 
GGH/GH-ratio 
?áglycosylated Hyl. 
% free GGH 
% free GH 
% free Hyl 
Table 4-1 
6-11 
Male 
(6/6) 
49+24 
38+15 
40±20 
31±14 
33±9 
26±6 
1.25±0.11 
71.7±5.6 
76.4±15.4 
71.3*16.7 
26.7±9.0 
years 
Female 
(9/7) 
38±17 
31±13 
30+12 
25±9 
26±13 
22±11 
1.25±0.14 
72.7±4.1 
73.3±8.9 
76.3*12.1 
45.3*12.4 
12-17 
Male 
(6/5) 
41 ±13 
39±11 
34*12 
32±11 
27±12 
25±8 
1.22*0.10 
73.7*3.5 
66.8*10.0 
66.4*13.7 
37.0*8.7 
years 
Female 
(5/5) 
39±24 
35+27 
18*3 
16±5 
16*2 
14*4 
2.15*1.30 
76.7*7.4 
77.2*8.3 
81.9*16.8 
43.8*13.4 
Adult 
Male Female 
(5/3) (7/6) 
18+3 
22±6 
11*2 
14*4 
14*5 
17±5 
1.65*0.11 
67.5*6.6 
81.3*8.3 
88.2*16.0 
37.3*19.9 
19+5 
23+5 
10*2 
12±3 
12*2 
15+2 
1.95*0.47 
70.0+5.5 
64.4*16.0 
78.9*21.2 
25.6*7.3 
pA 
<0.001 
0.02 
<0.001 
<0.001 
<0.001 
0.03 
0.02 
0.03 
0.84 
0.37 
0.27 
pS 
0.40 
0.29 
0.01 
0.006 
0.02 
0.005 
0.02 
0.24 
0.47 
0.53 
0.29 
pAS 
0.55 
0.64 
0.23 
0.11 
0.45 
0.23 
0.09 
0.89 
0.07 
0.29 
0.02 
Effect of age and sex on the excretion of total hydroxylysylglycosides and hydroxylysine and of their free fractions in 
normal subjects. Values are means ±SD. The numbers of individuals in which total hydroxylysine and its glycosides were 
determined, and the numbers of individuals in which both total and Free hydroxylysine and its glycosides were deter-
mined, are given successively within parentheses. The p-values pA, pS and pAS are the testing results as obtained by 
testing the hypothesis oF no age eFFect, no sex eFFect and oF no interaction between age and sex respectively according 
to a two-way analysis of variance. With respect to the absolute concentrations previously a logarithmic transformation 
has been applied to the data. 
Table 4-2 
Age 
Years 
GGHh GHa GH0 Hyla Hylb Ratio Sqlycogylatpd 
GGH/GH hydroxylysine 
»free 
GGH 
»Tree 
GH 
Sfree 
Hyl 
Alport patientq 
6-11 
12-17 
Adults 
<f (1/1) 57 
Q (5/4) 42*10 
(ƒ (3/3) 34±14 
О (4/4) 32±12 
(ƒ (5/3) 22i9 
J (12/11) 21t7 
52 
37±7 
22±3 
22±β 
4fl 43 31 28 1.19 77.5 68.8 71.3 36.В 
32*7 28*4 23*4 21*3 1.32*0.14 76.1*1.0 64.7*3.8 75.0*10.9 26.3±13.4 
46±14 26±14 35±15 15±8 1918 1.38*0.21 Я0.5±4.1 84.4*10.2 81.1*12.6 34.4*10.6 
32±10 20±10 20±7 17±7 17±5 1.67±0.29 75.4±2.1 84.3*13.6 92.3118.8 40.7±5.7 
13*10 11*3 16*9 15*4 1.89*0.48 69.4*2.7 51.2*17.7 77.3*19.0 12.6*8.4 
10±2 10±2 12±5 12*5 2.08*0.50 72.516.0 82.4120.2 98.7117.5 32.6110.0 
Alport sibs 
6-11 
12-17 
Adults 
О (1/1) 60 
dP (3/3) 37117 
Ç (3/3) 27*6 
J '2/2) 24*2 
Ç (1/1) 11 
60 46 47 43 
43125 27115 32*21 2618 
32*5 16*4 19*2 14*3 
31*7 13*5 17*8 15*3 
13 6 7 7 
44 1.30 
30114 1.5110.33 
18*6 1.70*0.11 
19*6 1.89*0.49 
В 1.81 
71.1 63.3 65.3 37.5 
68.817.4 72.0*23.0 82.1132.1 39.4115.4 
74.2*8.1 76.914.9 89.8*6.9 40.7*4.0 
71.4*0.1 76.2*20.7 83.7*19.2 24.014.5 
71.1 110 113.5 27.9 
Benign recurrent 
hematuria 
6-11 
12-17 
Ç (4/4) 45*13 
<f (5/4) 45*4 
Ç (1 /1) 53 
40*25 37*6 32*16 32*11 
46*7 39*6 40*5 28*3 
32 40 25 2B 
29*21 1.21*0.15 
28*6 1.1710.11 
17 1.31 
72.4*3.8 69.6*29.6 71.3*32.7 42.2*20.2 
75.4*2.3 57.6*25.7 59.1*24.5 33.3*14.4 
76.9 82.0 89.8 75.3 
IgA nephropathy 
6-11 rf(1/1) 38 
9 (2/2) 37*1 
«fd/D 64 
у (1/1) 14 
36 35 33 23 22 1.10 75.7 
32*6 31*1 26*5 33*4 28*1 1.20*0.01 67.1*3.4 
69 55 60 34 36 1.16 78.0 
29 β 17 13 26 1.68 63.6 
73.3 76.0 
73.7*0.4 77.8*5.9 
50.0 48.9 
56.6 41.3 
61.5 
41.8*2.6 
26.1 
30. a 
Acute glomerulo­
nephritis 
6-11 
12-17 
<S (2/2) 54*34 40*24 37*1628*1228*18 21*13 1.39*0.31 
¿ • ( I / I ) 61 56 44 41 33 31 1.39 
77.1*1.9 
75.8 
73.4*17.9 76.5*6.7 
60.9 50.7 
43.1*25.4 
31.7 
Membranoprolι fe rat ιve 
g lomerulonephr i t is 
6-11 J ( 2 / 2 ) 
ί> (1/1) 
12-17 ¿ 4 1 / 1 ) 
23*0 
32 
54 
28*10 
35 
61 
22*2 
31 
43 
27*6 
34 
49 
23*0 
26 
27 
29*9 
29 
31 
1.04*0.11 
1.03 
1.26 
66.1*0.9 
70.5 
78.0 
70.7*1.4 69.7*4.7 
92.7 88.1 
84.0 75.7 
32.7*11.7 
73.8 
26.9 
Nephrotic syndrome 
12-17 (f (6/6) 31*8 34*8 22*8 24*7 1916 2116 1.46*0.30 72.317.3 77.0121.8 77.617.5 
Henoch-Schonlein 
n e p h r i t i s JO'-» 
J (2/2) 4215 40*1 32*9 30*2 3115 3016 2317 22*2 
3117 
4919 
2311 
37*11 
1.39*0.09 
1.37*0.23 
70.017.0 
59.117.1 
69.517.4 
61.2*28.5 
82.6124.1 
71.4129.7 
37.3110.6 
21.8112.3 
apmol/g creat 
V n o l / 2 4 h 1.73 m2 
Table 4-2. 
Excretion of total hydroxylysine and its qlyrnsides and of their free Fractions in patients suffering from Alport's syndrome and 
their siblings, and patients with benign recurrent hematuria, IgA-nephropathy, acute glomerulonephritis, membranoproliferative 
glomerulonephritis, nephrotic syndrome and Henoch-Schónlein nephritis, divided into age and sex-groups. Values are means ISO. 
The number of individuals in which total hydroxylysine and its glycosides have been determined, and the number of individuals in 
which both total and free hydroxylysine and its glycosides have been detennined, are given successively within parentheses. 
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/umol/g créât, both groups of children excrete significantly more of 
each compound than the adult group (p<0.03). When the concentrations 
are expressed in jumol/24h 1.73 m2, the same results are obtained (pS 
0.05) with the exception of the hydroxylysine-content of the urine of 
12-17 years old children when compared to adults. 6-11 years old 
children have a significantly lower GGH/GH-ratio when compared with 
the adult group(p=0.04). 12-17 years old children have a higher 
percentage of glycosylated hydroxylysme than adults (p=0.03). There 
are no significant differences in the percentages of free 
hydroxylysme and its glycosides between the age-groups averaged over 
both sexes. 
Significant differences between both sexes can be established. Males 
excrete more GH and hydroxylysme, both when expressed in μmol/g creat 
and /umol/24h 1.73 m2. With respect to GGH there are no significant 
differences. Averaged over the age classes, males have a lower 
GGH/GH-ratio than females. The percentage of glycosylated 
hydroxylysme and the percentages of free hydroxylysme and its 
glycosides do not show significant sex-dependent differences, averaged 
over the age classes. 
For the comparison of the different patient groups both the factor sex 
and age have been taken into account. Concerning the age the same 
classes have been made use of as above. 
Firstly, with respect to each of the introduced variables, the linear 
hypothesis that, averaged over the six subgroups means, the mean for 
Alport patients is equal to the mean for normals, was tested. 
Regarding the absolute concentrations the tests have been carried out 
on the basis of both loganthmicly transformed data and the original 
data. 
It could be established that the Alport siblings excrete nearly 
significantly more hydroxylysme than the patients, when the 
concentration is expressed in AJmol/24h 1.73 m 2 without transforming 
the data (p=0.018; Bonferrom's principle). No further significant 
results were found (pè0.04). 
Secondly, in a similar way, the other patient groups are compared to 
normal persons and Alport patients. For each of the patient groups and 
variables the linear hypothesis that averaged over the non-missing 
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subgroups the mean is equal to the corresponding mean (i.e., averaged 
over the same subgroups) of the normals c.q. Alport patients, has been 
tested. Patients suffering from benign recurrent hematuria excrete 
nearly significantly more hydroxylysine than Alport patients, when the 
concentration is expressed in /jmol/g creat after transforming the data 
(p=0.0048). The percentage of glycosylated hydroxylysine in Henoch-
Schönlein nephritis is significantly lower than in Alport patients 
(p=0.0014), and nearly significantly lower than in normal subjects 
(p=0.0061). With respect to the other variables and the other patient 
groups no differences could be established (pä 0.01). 
4.5. DISCUSSION 
The excretion of total hydroxylysine and its glycosides pursues the 
same pattern as that of the free compounds i.e., children excrete more 
of each substance than adults, both when concentrations are expressed 
as /umol/g creat and as/umol/24h 1.73 m2. The peptide-bound fraction is 
equal both in children and adults, but it is different for GGH, GH, 
and hydroxylysine. According to literature, approximately lOJí of uri-
nary hydroxylysine is peptide-bound ( 7 ) . We observed, however, that 
generally more than 50% of the total hydroxylysine is peptide-bound. 
This high extent cannot be due to destruction of the hydroxylysyl-
glycosides by the hydrolysis procedure with concomitant release of 
hydroxylysine, since virtually no glycosides are destroyed by the 
alkaline hydrolysis under these circumstances ( 6) . Our recovery-
experiments gave similar results. GGH and GH appeared to be peptide-
bound in urine for about 25% on the average (Table 1). The GGH/GH-
ratio of total and free glycosides is similar. The lower percentage of 
free hydroxylysine compared to free hydroxylysylglycosides in urine 
will be related to the mechanism of degradation of the basement mem-
brane and other collagen types in the body, since hydroxylysine is 
glycosylated to a higher extent in basement membrane collagen than in 
the other collagen types. 
Literature on excretion of peptide-bound hydroxylysylglycosides is 
scarce. Most work was performed by Askenasi et al., using a dialysis 
method to obtain the peptide-bound fractions (9). In their experiments 
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in two normal subjects they observed the high GGH/GH-ratio oF 8 in the 
non-dialyzable Fraction. Due to the diFFerent methods oF analysis, it 
is not possible to compare their concentrations with our data in 38 
normal persons oF diFFerent ages. A somewhat more pronounced diFFeren-
ce between the sexes is observed in the excretion oF total hydroxyly-
sine and its glycosides than in that oF the Free compounds (4). 
In a Former study, no marked diFFerences in excretion rates oF the 
Free compounds between normals and patients suFFering From Alport's 
syndrome could be established (5), in contrast to data From the lite-
rature ( 2,3 ). It was suggested in that study, that investigation oF 
the peptide-bound Fraction oF urinary glycosides might be a better 
diagnostic approach oF Alport's syndrome. The high GGH/GH-ratio appea-
red to make this Fraction more speciFic For basement membrane collagen 
(6,8). The GGH/GH-ratio is 5.7 in the rat glomerular basement membrane 
and 3.7 in the human glomerular basement membrane versus 1.6 in human 
skin collagen and 1.3 in human tendon collagen. Sternberg et al. ob-
served in Wistar rats with nephrotoxic serum nephritis an increased 
urinary excretion oF both glycosides, which was mainly due to an ele-
vation oF the peptide-bound Fraction oF these glycosides (6). 
The GGH/GH-ratio oF the total hydroxylysylglycosides in urine increa-
sed From a mean oF 1.87 to a mean oF 2.51. We observed, however, no 
clear diFFerences in the percentages oF Free GGH and GH and in the 
GGH/GH-ratio oF the total hydroxylysylglycosides between controls and 
various groups oF patients. The observed decrease oF the percentage oF 
glycosylated hydroxylysine in Henoch-Schbnlein nephritis needs to be 
con Firmed. 
In conclusion, investigation oF urine on hydroxylysine and its glyco-
sides does not seem te be oF value For the diagnosis oF Alport's syn-
drome. IF there is an abnormal composition or turnover oF the basement 
membrane in this disease, it does not seem to be re Fleeted in these 
compounds in the urine, neither in the Free nor in the peptide-bound 
Form. Immunologic analysis oF basement membrane Fragments in urine may 
oFFer a better perspective (9). 
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5.1. ABSTRACT 
Renal biopsies of 65 children with isolated hematuria persisting for 
one year, were investigated by light microscopy, electron microscopy 
and irmiunofluorescence with antisera specific against basement 
membrane components. The majority of the biopsies (62/65) showed 
variable histologic abnormalities. Four categories could be 
distinguished on combined histological and clinical criteria: Alport's 
syndrome (8), benign hematuria (33, familial in 23), IgA nephropathy 
(16) and increase in mesangial cells and matrix (5). A renal biopsy 
was found to be indicated in children with isolated hematuria if a 
negative family history is present and a prognosis is required, it was 
not if benign hematuria occurs in other, adult male, family members. 
The use of the antisera against basement membrane components as were 
applied in this study does not allow a differentiation between 
Alport's syndrome and benign hematuria. Goodpasture serum gives a 
positive iimunofluorescence in the latter and a variable one in the 
former. 
5.2. INTRODUCTION 
Hematuria is the presenting symptom in a large number of renal 
disorders. It will often be accompanied by hypertension, impaired 
glomerular filtration or proteinuria. If the hematuria occurs in 
childhood, is isolated and of glomerular origin, the differential 
diagnosis is rather limited. Alport's syndrome, benign hematuria and 
IgA-nephropathy are the most prevalent conditions. Identification of 
the underlying disease and, particularly, differentiation between 
Alport's syndrome and benign hematuria are necessary for prognosis 
and genetic counseling. Light microscopy does not play an important 
role in this differentiation. 
The specificity of the ultrastructural lesions observed in Alport's 
syndrome has been extensively discussed (Hinglais et al. 1972; Hill et 
al. 1974; Kohaut et al. 1976). Like Habib et al. (1982) we consider 
the more prominent lesions highly suggestive for Alport's syndrome. 
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On the other hand, the finding of extensive attenuation of the 
basement membranes suggests a benign hematuria. An accurate diagnosis 
can only be established both by careful examination of the family, and 
a renal biopsy, studied with light microscopy, electron microscopy and 
immunofluorescence. Jems et al. (1981) reported a variable staining 
of the glomerular basement membrane of glomeruli in Alport's syndrome 
using anti-glomerular basement membrane sera. Investigation of the 
basement membranes with antisera against basement membrane components 
therefore might be helpful for the diagnosis. 
In the present study, the results of studies in 65 children with 
isolated hematuria, observed over a 10-year period, will be 
described. The prevalence of abnormal renal histology is reported and 
different histological categories are presented and compared with the 
findings of the only similar study of Trachtman et al. (1984). 
Based on these findings a guideline for the study of isolated 
hematuria in childhood is proposed. 
5.3. METHODS 
Patients and family studies 
From January 1975 through July 1985 renal biopsies were obtained 
from 65 children with isolated hematuria. All patients had a normal 
glomerular filtration rate and no proteinuria, hypercalciuna or 
hypertension. The hematuria was present in all patients for at least 
one year; it is defined as a condition with 10 or more erythrocytes 
per mm^ urine, established by the quantitative sediment, method of 
Gadeholt (1968). 
Those parents of patients in whom Alport's syndrome or benign hema-
turia was diagnosed, completed a family questionnaire. Thus, details 
with respect to familial hematuria, renal insufficiency and deafness 
were collected. An urine specimen from all first-degree relatives of 
the patients was used for the determination of protein content, and of 
the number of erythrocytes by the quantitative sediment. The glomeru-
lar filtration was estimated from serum creatinine. 
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The biopsy specimens were investigated by light microscopy, 
electron microscopy and intnunofluorescence. 
Tissue processing 
Biopsy fragments were fixed in Bouin's solution, dehydrated and 
embedded in paraplast (Amstelstad, Amsterdam, The Netherlands). 
Sections of 2 μ were stained with hematoxylin and eosin, periodic acid 
Schiff and silver methenamine according to Jones (1957). Furthermore, 
2 μ-sections were cut in a cryostat from tissue fragments snapfrozen 
in liquid nitrogen. A direct immunofluorescence technique was applied 
using monospecific fluorescein-labelled rabbit antisera directed 
against human γ, μ, α, C1q, C3 and fibrin. Specific antisera against 
collagen IV, laminin, fibronectin and proteoglycan were applied 
(Foidart et al. 1980 and 19Θ3). Binding of these antisera was 
visualized by the indirect immunofluorescence technique with 
monospecific fluorescein-labelled swine anti-rabbit Ig (Dakopatt, 
Copenhagen, Denmark). The presence of the Goodpasture antigen was 
studied in the same indirect immunofluorescence technique using a 
serum from a patient with an anti-glomerular basement membrane 
disease, the binding of which was examined by a fluorescein- labelled 
anti-human Ig (Dakopatt). The staining intensity was recorded 
semi-quantitatively in a Leitz fluorescence microscope with a 
Ploemopak epi-illuminator.Small pieces of the biopsies were fixed in 
2.5% glutaraldehyde (2 h), washed in cacodylate buffer, postfixed in 
phosphate-buffered 2% 0s04 (1 h), dehydrated in increasing percentages 
of alcohol, and finally embedded in Epon Θ12. Ultrathin sections, 
stained with 5% uranyl acetate (30 min) and lead citrate (3 min), were 
examined in a Siemens Elmiskop 101 at a magnification of χ 48,000. 
The basement membrane thickness was only measured in the patients 
suffering from benign hematuria. All peripheral capillary loops (5-15) 
clearly in cross section, were evaluated. The measured values included 
those of both laminae rarae. Both the width and the length of the 
basement membrane were measured with a vernier calliper and curvimeter 
respectively. From these values the means and standard deviations were 
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Fig.5.1: Basement membrane thickness in θ children of different ages, 
suffering from minimal lesion nephrotic syndrome. 
calculated as well as the percentages of thin basement membrane. The 
lower limit of normal basement membrane thickness was considered to be 
250 nm (including the laminae rarae), based on measurements in 8 
children with minimal lesion nephrotic syndrome (figs. 1 and 2a). 
Alport's syndrome was diagnosed when the characteristic malformations 
of the glomerular basement membrane i.e., reticulation- or 
feuilleté-aspect with irregular thickness of the glomerular basement 
membrane, were prominently present (fig. 2b). The over-all picture in 
benign hematuria consisted of long sections of thin glomerular 
basement membrane (fig. 2c). 
Complement study 
The complement system was investigated in 11 patients with benign 
hematuria by determination of the serum concentrations of C3c, C4, Clg 
and C3 proactivator. C4 hemolytical activity was determined according 
to the method of Gaither et al. (1974). 
5.4. RESULTS 
In 8 cases an Alport's syndrome could be diagnosed by the specific 
500-
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Fig.5.2: a Normal glomerular basement membrane. 
b Irregular reticulation- of "feuilleté"-basement membrane in 
Alport's syndrome. 
с Thin basement membrane in benign hematuria. 
Original magnification χ 12,800. 
ultrastructural lesions and a positive family history (fig. 3). 
Thirtythree children were classified as benign hematuria. In this 
group of patients, hematuria was familial in 23 (70%). The pedigrees, 
shown in fig. 4, are compatible with a dominant inheritance in most of 
them. The affected family members were unaware of hematuria. Serum 
106 
Ν 
АО 
30-
20 
10-
Μ Alport Benign Poststr IgA 
haematuna GN nephropathy 
Fig.5.3; Diagnosis in 65 children with isolated hematuria, and 
familial cases in the four groups. GN = glomerulonephritis. 
N = number of patients investigated. 
creatinine was normal in all of them. There was no proteinuria. These 
33 patients were divided into a group (23 patients) that showed 
generalized thin GBM in the electronmicroscopy (i.e., thin over more 
than 50% of the total length), and another one (10 patients) with less 
evident attenuation. The familial occurrence in both groups was 
not significantly different from each other (1Θ/23 and 5/110 
respectively; exact Fischer test for 2x2-table: p=0.21). The width of 
the GBM in the familial cases was 252 + 71 nm (mean + SD), in the 
non-familial 269 +_ 93 nm. Sixteen of the 65 children appeared to 
suffer from IgA-nephropathy. Five cases showed other, aspecific, 
abnormalities: the mesangium was slightly increased by both an 
increase in cells and matrix, whereas in the immunofluorescence minor 
mesangial depositions of IgG, IgM or C3 were seen. Postinfectious 
mesangial glomerulonephritis might be speculated in these cases. In 3 
children with isolated hematuria no abnormalities could be established 
by either light microscopy, immunofluorescence or electronmicroscopy. 
The biopsy specimens of children suffering from Alport's syndrome 
(6) and benign hematuria (6) were investigated with antisera specific 
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Fig.5.4: Pedigrees of the familial cases of benign hematuria. 
• ·= hematuria. 
against glomerular basement membrane components, and compared to 
biopsies of minimal lesion nephrotic syndrome (5). The anti- laminin, 
anti-fibronectin and anti-proteoglycan antisera did not allow a 
differentiation between Alport's syndrome and benign hematuria (Table 
1). The basement membrane and mesangium in Alport's syndrome and 
benign hematuria stained with anti-collagen TV slightly less when 
compared with the controls. In Alport's syndrome, the Goodpasture 
antiserum gave variable results: 3 patients showed a positive, 3 a 
negative reaction. A positive reaction was always present in benign 
hematuria. 
Both the serum concentrations of C3c, C4, Clq and C3 proactivator 
and the C4 hemolytical activity were normal in all 11 patients with 
benign hematuria studied. 
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Antiserum 
Collagen Fibronectin Laminin Proteoglycan Goodpasture 
IV antigen 
Minimal lesion 
nephrotic syndrome 
(n = 5) GBM ++++ 
TBM ++++ 
Mesangium + 
Alport's syndrome 
(n r 6) GBM -M-/+++ 
TBM 
Mesangium 
Benign hematuria 
(n = 6) GBM 
TBM 
Mesangium 
+/++ ++-M-
+/++ ++++ 
ι ι ι ι _+ 
+/-H-
+ +++/1 I I I +/++ 
++/+++ +++/1 I I I 
+•4-+/++++ 
+ 
+ 
+(n=3), 
-(n=3) 
+(n=3), 
-(n=3) 
Table 5.1: Reaction of anti-GBM-component specific antisera with 
biopsy specimens of patients with minimal lelion nephrotic 
syndrome, Alport's syndrome and benign hematuria. 
5.5. DISCUSSION 
In the majority of 65 children with isolated hematuria of glomerular 
origin basement membrane pathology proved to be present. An important 
diagnostic problem concerns the differentiation between Alport's 
syndrome and benign (familial) hematuria. In the typical cases of the 
former electron microscopic evaluation of the renal biopsy specimens, 
together with the clinical findings (deafness) and a family history of 
renal failure, facilitate the diagnosis. Unfortunately many cases are 
much less typical. In patients with basement membrane alterations, 
hematuria associated with normal renal function may be observed, even 
in male adults. As is shown in this study, a reliable diagnosis can 
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only be reached by a careful family investigation. Normal renal 
function in male adults with hematuria and basement membrane pathology 
appeared to be highly suggestive for familial benign hematuria. 
Unfortunately, normal thickness of the glomerular basement membrane 
has not been properly defined. According to Bloom et al. (1959) ita 
width increases from some 100 nm at birth to a mean of some 270 nm at 
3 years of age and above. Osawa et al. (1966) observed in 21 adult 
individuals a mean value of 315 nm, and a standard deviation of 98 
nm. In our control group these data are 372 and 90 nm, respectively. 
Most authors regard as lower limit of basement membrane thickness a 
value of 150 nm (Rumpelt 1980, Trachtman et al. 1984) or 250 nm 
(Yoshikawa et al. 1984). The reason for the different values may be 
due to differences in fixation and processing. Like Yoshikawa et al. 
(1984) we compared our biopsy specimens with those of patients with 
minimal lesion nephrotic syndrome and regarded a basement membrane as 
thin, when it had a width of under 250 nm. The method of measuring the 
basement membrane width is comparable to that of other authors 
(Rumpelt 1980, Tina et al. 1982, Yum and Bergstein 1984, Trachtman et 
al. 1984, Yoshikawa et al. 1984). The measured values included those 
of both laminae rarae, a procedure followed in the other studies 
cited. As is well known the borders of the lamina densa are often very 
fuzzy, impairing an accurate determination of the width of the lamina 
densa. 
We differentiated our group, like Yoshikawa et al. (1984), in 
Alport's syndrome, IgA-nephropathy, familial and non-familial 
hematuria, the last two groups on the basis of low values of the width 
of the basement membrane. Yum and Bergstein (1983) differentiated 
their material on ultrastructural criteria into 3 groups. Type 1 
basement membrane nephropathy is characterized by irregular and marked 
thickening of the glomerular basement membrane, accompanied by severe 
structural distortion, type TI by diffuse attenuation of the 
glomerular basement membrane, particularly of the lamina densa, and 
type III by only a slight variation in glomerular basement membrane 
thickness. We were unable to identify their latter type III. We 
compared our results with those of Trachtman et al. (1984) (Table 2), 
110 
Diagnosis Present series Trachtman et al. 1984 
Alport's syndrome θ 9 
Benign hematuria 33 17 
familial 23 ? 
non-familial 10 7 
IgA nephropathy 16 θ 
Other abnormalities 5 9 
No abnormalities 3 33 
Total 65 76 
Table 5.2: Comparison of data obtained in this study with those of 
Trachtman et al. (1984). 
and found that benign hematuria associated with thin basement 
membranes was more prevalent in our group than in theirs. The vascular 
C3 staining observed in their study, however, was found to be not 
characteristic and seen in many other glomerular disorders. Hematuria 
existed in our group for a longer period: one year versas six months 
in Trachtman's group. The large series of Habib et al. (1976) shows in 
137 patients 86 cases of IgA nephropathy, 30 of Alports syndrome, and 
8 of benign hematuria. In 12 cases no abnormalities were found. This 
study is not comparable with our study, because in all children the 
hematuria was macroscopic. We were unable to confirm the findings of 
Welch et al. (1984), who observed a diminished C4 hemolytical 
activity, with normal complement components, in 9 out of 24 patients 
with benign hematuria. 
In the present study the percentage of familial cases of benign 
hematuria is remarkably large. Unfortunately, most other comparable 
studies pay little attention to this familial occurrence. Miller et al 
(1985) reported in the families of 76 patients 25^ affection. Patients 
with an Alport's syndrome were excluded from theirstudy. We were not 
able to demonstrate a difference in mean basement membrane width 
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between familial and non-familial benign hematuria, as was described 
by Tina et al. (1982). 
Investigation of a quantitative sediment proved to be necessary to 
detect the otherwise symptomless cases. None of the family members 
with microscopic hematuria was aware of this symptom. If the 
evaluation of the family of a patient with isolated microscopic 
hematuria makes an Alport's syndrome less probable (for instance when 
the father has hematuria with otherwise normal renal function), benign 
familial hematuria can fairly well be established and a renal biopsy 
generally be avoided. A familial occurrence of benign hematuria 
provides an argument in favour of a metabolic disorder of the basement 
membrane. 
Investigation with antisera specific for glomerular basement 
membrane components failed to be useful in the differentiation between 
Alport's syndrome and benign hematuria, as was described earlier 
(Habib et al. 19Θ2). In both conditions, the slightly decreased 
staining with anti-collagen IV might be an indication for a diminished 
collagen IV content. In Alport's syndrome there are indications for a 
diminished collagen content (Habib et al. 1982, DiBona. 1983). In 
benign hematuria the decrease may be explained by the widespread 
attenuation of the glomerular basement membrane. 
Variable results with Goodpasture antiserum in Alport's syndrome 
have been described earlier (Olson et al. 1980, Jenis et al. 1981, 
McCoy et al. 1982, Jeraj et al. 1983). As the Goodpasture antigen is 
part of the collagen molecule (Wieslander et al. 1984), the 
composition and/or structure of the collagen in this syndrome may be 
abnormal, although variations in masking of the antigen may not be 
excluded. The variability in reactivity of glomerular basement 
membrane with Goodpasture antiserum may be due to more or less 
sequestration of the Goodpasture antigen inside the hexamer of the 
globular domains of type IV collagen (Wieslander et al. 1985). An 
absent or weak reaction of the Goodpasture antiserum with the 
glomerular basement membrane of young children ( <3 years of age) is a 
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common observation. As the children in our study were over 7 years 
old, the maturation of basement membrane can be assumed to be 
completed (Anand et al. 1978, Jeraj et al 1984, Veerkamp 1986). There 
was no correlation between the degree of the ultrastructural lesions 
and the staining with Goodpasture antiserum. It should be noted that 
the irmunofluorescence with Goodpasture antiserum in benign hematuria 
was always positive. 
In conclusion, renal biopsy is indicated in children with isolated 
hematuria if the family history is negative. The biopsy is important 
For diagnosis of the underlying disease, genetic counselling and 
prognosis (Miller et al. 1985). Careful electron microscopic 
examination of the glomerular basement membrane, together with 
thorough investigation of the family, may lead to a reliable diagnosis 
in virtually all cases. One must be aware, however, that only 
extensive basement membrane attenuation does not guarantee a benign 
course of the disease, as progressive renal failure may occasionally 
develop (Habib et al. 1982). If isolated hematuria is also established 
in adult male family members, delay or even omission of the biopsy is 
justified. One should always keep in mind that the isolated hematuria 
may be due to an other disease. Such a coincidence, however, is not 
likely. Immunofluorescence with polyclonal antisera against basement 
membrane components seems to have only limited value in the diagnosis 
of this group of diseases. Recently, Savage et al. (1986) showed an 
absence of the Goodpasture antigen in ten patients with Alport's 
syndrome, using a monoclonal antibody. This approach may be promising 
for further research in this field. 
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6.1. ABSTRACT 
Alport's syndrome is inherited in three different modes: autosomal 
dominant, X-Linked dominant and autosomal recessive. For the autosomal 
dominant form linkage and association with the HLA-system have been 
reported. In a group of 35 patients taken from the Eurotransplant file 
with the diagnosis of Alport's syndrome, no association with any par­
ticular HLA-class I or class II antigen has been observed. Within four 
multicase families an X-linked form of inheritance could not be exclu­
ded. In none of the families linkage with HLA was observed. 
6.2. INTRODUCTION 
Several theories about the occurrence of Alport's syndrome and the 
mode of inhpntance have been observed. For a long time a sex-influen­
ced, autosomal dominant mode of inheritance was most widely accepted 
(Preus and Fraser, 1971). Other authors state an X-linked dominant in­
heritance (O'Neill et al., 197Θ). МсКичіск (19B6) proposed three dif­
ferent modes of inheritance based on data obtained from an extensive 
review of the available literature. Besides autosomal dominant and X-
linked dominant inheritance, Alport's syndrome may also occur as an 
autosomal recessive disease. Linkage with HLA-antigens has been repor­
ted (Ono et al., 19B0). We performed linkage-studies in four large fa­
milies. Because association was also reported in the literature (Ha­
shimoto et al., 19Θ3), we utilized the HLA-types of 35 kidney trans­
plant candidates with Alport's syndrome present in the Eurotransplant 
file. 
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6.3. METHODS 
Patients 
In the Four Families, diagnosis was based on clinical course, Fami­
ly history and the typical electronmicroscopic patterns oF renal biop­
sies (Rumpelt, 1980) in at least one member oF the Family. Red blood 
cells in Fresh urinary specimens were quantitated, using the method oF 
Gadeholt (196Θ). Renal Function was determined by creatinine clearan­
ce, calculated on 24-hour urinary specimens, or, when not available, 
on serum creatinine. Audiographies were perFormed in all investigated 
patients. The pedigrees oF the Four Families studied are depicted in 
Fig. 6-1. 
Fig. 6-1 
Family 1 
a b i 0 - ; 0 c d Ж 
φ <s> <г> <3> I 
a = A30, B13 
b = A32, B35 
с = A11, B7 
d = A l , B7 
ρ = A3 , B7 
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Fig . 6.1 ( c o n t . ) 
Family 2 
ab 0- cd Ш 
π 
I 
a = A 1 , B8 , DR3 
с = A l , B37, DR1 
d = A9, B5 , DR4 
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Family 4 
1 bie b..f b+e a+t f i 
>%? Ρ ¿ Ρ Ρ > 
e- -g fh· -li _ 
© φ,ι: 
Ш 
Ш 
π 
I 
a = Al, B51 
b = Al, BX 
с = Al, В49 
d = А1, В44 
e = ΑΙ , B51 
f = A31, B39 
g = A2 , BW60 
h = A2 , B8 
i = А28, В44 
j = A2 , BW62 
к = А2 , В7 
1 = А2 , В51 
m = A28, B60 
π = A25, B1B 
Fig. 6.1 Pedigrees of the described families. 
Keys: upper left shadowed-hematuria; upper right ahadowed-
renal insufficiency; lower left shadowed-deafness; lower 
right ahadowed-ocular malformation. 
An asterisk marks the biopsied patients. 
Thirty-five Dutch Causasoid renal allograft recipients from the Euro-
transplant file with the diagnosis of Alport's syndrome were used for 
the HLA-association studies. The HLA control frequencies were obtained 
from 1018 healthy unrelated Dutch Causasoids. Some of the patients and 
controls were not completely typed for some HLA-antigens. 
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HLA-typing 
HLA-ABC-typing was done with standard NIH-microlymphocytotoxicity 
assays. HLA-DR-typing was done either with B-lymphocyte suspensions 
after enrichment with AET-treated sheep red blood cells, or with the 
two-colour fluorescence (TCF) technique. Patients from the Eurotrans­
plant file had been typed twice in two independent laboratories. The 
sera used for typing DR1-DR10, DQW1-DQW3 and DRW52-DRW53 were partly 
of local origin and all sera were standardized against 9th Internatio­
nal Workshop reagents. 
Statistical analysis 
Haldane's modification (1955) of Woolf's method (1955) was used to 
assess the significance of the differences in the antigen distribu­
tions on the patients and control populations. Edwards' method (1974) 
was used to correct ρ values for the number of antigens tested. 
6.4. RESULTS 
Family studies: analysis of linkage. 
The mode of inheritance in all four pedigrees is concomitant with a 
dominant one. A male/female ratio of 13/22 was observed. The distribu­
tion of the HLA-antigens in the families makes clear that no linkage 
is present (figure 1). 
Inspection of the Eurotransplant file; association-study. 
The male/female ratio of 30/5 in the patients was significantly 
different from the expected 1/1 ratio (p = 0.0001). Three HLA antigens 
(A32, B18 and BW53) were significantly heterogeneous in the patients 
and controls (table 1). All were elevated in the patients. None of the 
differences remained significant after correction for the total number 
of antigens tested. The observed numbers of HLA-A and -B locus pheno-
types were not significantly different from the Hardy-Weinberg expec­
tations. 
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Table 6-1; HLA antigen heterogeneity in patients with Alport's syndro­
me. R.R. = relative risk. 
Antigen Patients Controls R.R. X 2 
+ - + 
A32 4 2Θ 55 962 2.738 4.005 0.043 
B18 5 28 73 945 2.483 3.833 0.047 
BW53 1 29 5 1011 9.351 7.129 0.008 
6.5. DISCUSSION 
In Alport's syndrome three different modes of inheritance are assu­
med (McKusick, 1986; Gubler et al., 1981). Most authors suppose an au­
tosomal dominant inheritance, sex-influenced (Preus and Fraser, 1971; 
Kenya et al., 1977) or an X-linked dominant inheritance (O'Neill, At-
kin and Bloomer, 1978; Tishler, 197B). Due to the reports of Passwell 
et al. (1981) and Gubler et al. (1981), autosomal recessive inheritan­
ce has gained new interest. Nevertheless, this last form seems to be 
rare. 
In the families described here X-Linked dominant inheritance cannot 
be excluded. The male/female-ratio in the familial cases is comparable 
with figures obtained from literature (Preus and Fraser, 1971; O'­
Neill, Atkin and Bloomer, 1978; Evans et al., 1980). We observed a 
marked departure from the expected 1:1 ratio in the renal allograft 
recipients with Alport's syndrome. An explanation for this male predo­
minance may be the generally milder clinical course in female pa­
tients, who less often develop endstage renal disease (Griinfeld et 
al., 1985). The predominance of males over females in the overall Eu-
rotransplant population may be another confounder. 
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There is no case oF father to son transmission in our study oF the 
Families. Ono et al. (19B0) investigated a Japanese Family and Found a 
possible linkage oF Alport's syndrome with a AW31, BW51 and DW1 haplo-
type. In that Family, however, a case o F Father to son transmission oF 
the disease is obvious. This may indicate another genetic mode oF 
transmission i.e., autosomal dominancy. 
Hashimoto et al. (1983) Found a positive HLA association: the Fre-
quency of HLA-DR4 was significantly higher in a population of 17 Al-
port patients than in a control population. We observed positive HLA 
associations for A32, B18 and BW53, but their significance levels did 
not remain after correction For the number of antigens tested. 
It might be concluded that there may be three genetic variants of 
Alport's syndrome: an autosomal dominant type, which may be linked to 
the HLA-system; an X-linked dominant type with no relation to HLA; and 
a rare autosomal recessive type, for which no figures about HLA are 
known. Further studies are needed to verify these statements. 
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7.1. ABSTRACT 
Alport's syndrome is an etiologically heterogeneous disease, sho-
wing different patterns of heredity. Both X-linked dominant, autosomal 
dominant and autosomal recessive forms of Alport's syndrome exist. A 
linkage analysis was performed in three families with X-linked Alport-
's syndrome using various DNA-probes. A close linkage was established 
between the Alport's syndrome gene and a polymorphic DNA marker DXS 17 
defined by probe S9. The gene is localized in the middle of the long 
arm of the X-chromosome. From these results it is concluded, that the 
use of DNA-probes may become a reliable tool for carrier detection and 
prenatal diagnosis of the disease. Furthermore, these observations 
will facilitate the search for other closely linked diagnostic markers 
of the gene m order to improve the diagnostic accuracy of this me-
thod. 
7.2. INTRODUCTION 
Three modes of inheritance are assumed to exist in Alport's syndro-
me (McKusick, 1986): an X-linked dominant, an autosomal dominant and 
an autosomal recessive mode. Of these three, autosomal recessive inhe-
ritance is probably rare. The relative contribution of X-linked domi-
nant and autosomal dominant inheritance in Alport's syndrome is un-
known though most authors consider X-linked inheritance as the most 
common (Feingold et al., 1985). 
Recently, Menlove et al. (1985) showed linkage of the gene for X-
linked Alport's syndrome to DNA-probes from the centromenc region of 
the X-chromosome in three Utah kindreds. In the present study, data 
from three European families (one from Germany and two from the Ne-
therlands) are presented. 
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7.3. PATIENTS 
Three families with Alport's syndrome were investigated (see Fig. 1 
for clinical details). Diagnoses were confirmed by renal biopsy in at 
least one member of each family. 
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F i g . 7 - 1 ; Pedigrees o f the i n v e s t i g a t e d f a m i l i e s . 
Key: upper l e f t shadowed-hematuria; upper r i g h t shadowed-
i m pa i red r e n a l f u n c t i o n ; lower l e f t shadowed-deafness; lower 
r i g h t shadowed-ocular m a l f o r m a t i o n . 
An a s t e r i s k marks the b i o p s i e d p a t i e n t s . 
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The typical ultrastructural lesions i.e. focal thickening and feuille-
té aspect of the glomerular basement membrane as well as intramembra-
neous granules were found in each biopsy specimen. Family members were 
considered affected if a fresh voided urinary specimen contained more 
than ID erythrocytes per mm' (Gadeholt, 196Θ). Renal function was de­
termined by creatinine clearance calculated on 24-hour urinary speci­
mens. In a few patients only single serum creatinine measurements were 
obtained. Audiographic examination was routinely performed in all in­
vestigated patients. Ophthalmologic examination was performed only if 
complaints or symptoms were present. 
METHODS 
DNA was extracted from leucocytes of 10 ml of EDTA-anticoagulated 
venous blood by standard procedures (Aldridge et al., 1984). 4 yg of 
genomic DNA was digested to completion with restriction enzymes Tag I 
or Msp I (Boehringer, Mannheim) as specified by the manufacturer. DNA 
was electrophoresed in 0.7% agarose gels and transferred to Gene 
screen (New England Nuclear) membranes by Southern blotting (Southern, 
1975). '2p_i
a
beled DNA-probes were hybridized for 24 hours at 65°C 
(Wieacker et al., 1984). Autoradiography was performed for 3 days at 
-70oC using double intensifying screens. For linkage analysis a recent 
version (3.5) of the LINKAGE program package was employed, which was 
kindly provided by Dr. Jürg Ott (Zurich, Switzerland). 
7.4. RESULTS 
A total of 54 persons were tested employing 8 X-chromosomal mar-
kers. Four of these markers were informative; the results are summari-
zed in Table I. Tight linkage was found between the gene coding for 
X-linked Alport syndrome (XAS) and the DXS 17 locus, defined by probe 
S9 which has been assigned to bands q 21.3 - q 22 of the X-chromosome 
(Drayna et al., 1984; Wieacker et al., 1984). Two definite cross-overs 
were observed in 26 informative méioses giving a maximum lod (log of 
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Regional Lod-scores at different recombination fractions (6) 
Locus Probe Localization 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 
DXS 7 Ll.28 Xp 11.3 - » -3.491 -1.896 -1.063 -0.551 -0.221 -0.016 0.096 0.131 0.098 
DXYS 1 pdP34 Xq 13-Xq 21 - » -1.491 -0.498 -0.017 0.245 0.381 0.428 0.406 0.325 0.190 
DXS 17 S9 Xq 21.3-Xq 22 - » 2.702 2.757 2.534 2.179 1.738 1.236 0.714 0.271 0.024 
DXS 11 22.33 Xq 24-Xq 26 1.505 1.394 1.276 1.152 1.021 0.880 0.731 0.570 0.396 0.207 
Table 7-1 : Results from linkage analysis between XAS and 4 DNA markers. 
odds) score of 2.785 at θ = 0.079. Thus, the estimated recombination 
fraction between the XAS gene and DXS 17 in our material is 7.9" (90% 
confidencp limits 2-23*0). No recombination was observed in 5 méioses 
between XAS and the DXS 11 locus (probe 22.33) which maps slightly be-
low DXS 17 in the same region of the X-chromosome and seems to be 
tightly linked to this marker (Drayna and White, 1985). Our data are 
not informative as regards the relative order of XAS, DXS 17 and DXS 
11 on the X-chromosome. In one meiosis, however, a cross-over event 
was observed with both DXS 17 and the DXYS 1 locus as defined by probe 
pdP 34. Given the relatively small genetic distance between DXS 17 and 
DXYS 1 of 12.5 ± 5.85Í (Drayna and White, 1985) this points to a 
location of XAS distal from DXS 17 within or below band Xg 22 since 
any other location would require at least two cross-overs in this 
chromosome segment. For XAS and DXYS 1, lod scores argue against close 
linkage, which is in keeping with this assignment, and the same is 
true for DXS 7 (probe L 1.28) and XAS. Testing with probes 19.2 (DXS 
3) and 52.A (DXS 51) was not informative in our material, as was 
testing for colour blindness and the Xg blood group. 
7.5. DISCUSSION 
X-linked dominant inheritance of Alport's syndrome has been assumed 
for the pedigrees from Utah, USA (O'Neill et al., 1978; Hasstedt and 
Atkin, 1983). Recently, X-linkage was confirmed by Menlove et al. 
(1985), who showed linkage between X-chromosomal markers and the XAS 
gene. They found a maximum lod score of 7.66 at a recombination frac-
tion (θ) of 0.22 for XAS and Ρ 19.2 (DXS 3) and a maximum lod score of 
2.57 at a recombination fraction of 0.25 for XAS and ΡΘ (DXS 1). The 
authors concluded to a probable localization of XAS in the centromeric 
part of the X-chromosome long arm. 
The present study shows, that in our material the XAS gene may be 
localized in the middle portion of the long arm in the vicinity of DXS 
17 (bands q 21.3 - q 22) and DXS 11 (Xq 24-26). The genetic distance 
between DXS 17 and DXS 1 has been estimated as 12.5 ± Ч.&Ч and the 
distance between DXS 17 and DXS 3 as 5.9
 ± Ъ 1% ( D r a y n a a n c) white, 
132 
19Θ5). Given the gene order suggested by our results, the observations 
of Menlove et al. (19Θ5) would predict a genetic distance of 10-15 cm 
between XAS and DXS 17 which is only slightly more than the value ob­
tained in our study. Therefore, our data are compatible with the ear­
lier American report of Menlove et al. (19Θ5). Fig. 2 gives a graphic 
representation of the situation. 
Xp 
centromere — 
11 
Xq 
— Xg 180-1 
Ше- Π 28 (DXS7) 
J - ΡΘ (DXSD 
. p d P 3 4 (DXYS 1 ) 
- - 19 2 (DXS 3) 
6 0 -
i - S9 (DXS 17) 
" ^ 2 2 33 (DXS 11) 
\ 4 0 -
4 ,
> 1 — 5 2 A ( D X S 51) 
O-l L colour blindness 
-22" 
25 
Fig. 7-2: Physical and genetic linkage map of X-chromosomal markers 
used in this study. Figures on the left indicate cytogenetic 
bands. Genetic distances are represented in recombination 
units on the right (data from Drayna and White, 1985). Pro­
posed localization of the XAS gene is indicated with 903! 
confidence limits. Recombination fractions from the study of 
Menlove et al., 1985 (*) represent peak Lod-scores since 
confidence limits were not specified. 
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Taken together, these data suggest that X-linked Alport's syndrome is 
a homogeneous disorder in different populations and that the XAS gene 
is located below (distal from) DXS 17 in the close vicinity of DXS 11. 
In our material DNA analysis correctly predicted the phenotypic status 
in 24 out of 26 méioses. This approach therefore may become a useful 
adjunct to existing methodology for early clinical diagnosis and car-
rier detection. Also, DNA analysis is feasible on both chorionic villi 
and amniotic fluid cells. This opens up the possibility of prenatal 
diagnosis of this disease. However, further studies in large XAS pedi-
grees will be necessary in order to narrow down the confidence limits 
of the genetic distances between XAS and the relevant marker genes be-
fore this approach can be applied in a clinical setting. Other closely 
linked diagnostic markers from the same X-chromosome segment may im-
prove the diagnostic accuracy of this method. 
When a family presents for genetic counselling it can be extremely 
difficult to decide between X-linked dominant and autosomal dominant 
inheritance. In such families, showing linkage to DXS 17 or DXS 11 can 
provide additional evidence for X-linkage. Unfortunately, only large 
kindreds will contain a sufficient number of informative méioses to 
make this approach practicable for counselling purposes. At any rate, 
linkage studies with these markers should soon clarify what proportion 
of Alport's syndrome cases belong to the X-linked or to the autosomal 
variety. 
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CHAPTER 8 
GENERAL DISCUSSION 
β. GENERAL DISCUSSION 
The discussion will be focused on two aspects: the biochemical lesion, 
and the diagnosis of Alport's syndrome. Some remarks with respect to 
the treatment will be made. 
8.1. THE BIOCHEMICAL LESION IN ALPORT'S SYNDROME 
There is increasing evidence that Alport's syndrome is a metabolic 
disorder of the basement membrane. The fact that it is an inherited 
disease and the presentation of the syndrome in different organs as 
kidney, ear, and eye formed the earliest indications for this hypo­
thesis. The typical ultrastructural malformations of the glomerular 
basement membrane supplied additional arguments. The finding of abnor­
malities in the biochemical composition of the glomeruli in this dis­
ease brought further support (Habib et al., 1982; DiBona, 1983). 
They reported a decreased content of hydroxyproline, hydroxylysine and 
half-cystine, although DiBona did not apply a statistical analysis to 
his data. These observations, however, need critical evaluation, since 
their findings probably are aspecific, and related to the endstage of 
renal disease. Westberg and Michael (1973) thoroughly investigated 
endstage kidneys of various renal diseases, compared them to an ade­
guate control group, and observed in chronic membranoproliferative 
glomerulonephritis, idiopathic membranous glomerulonephritis, and 
chronic pyelonephritis a decreased content of 3-hydroxyproline, 4-
hydroxyproline, hydrolysine and glycine, and an increased content of 
lysine (Table 1). These differences could not be explained by 
contamination of the diseased pathological glomerular basement 
membrane with interstitial collagen, because of the decreased content 
of glycine and 4-hydroxyproline. Investigation of the kidneys in 
earlier stages of the disease may provide a more reliable indication 
of the biochemical abnormality. Methods for biochemical analysis of 
biopsy specimens on a microscale have to be developed. Antisera, 
specific against (certain domains of) basement membrane components may 
be useful for immunologic investigations. Another possibility is to 
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Westberg and M i c h a e l , 1 9 7 3 
mean ± SEM 
Normal CMPGN CPN 
N=10 N=5 N=6 
3 - H y d r o x y p r o l i n e 1 8 . 5 ± 0 . 9 8 . 0 ± 0 . 9 * 1 2 . 4 ± 0 . 8 * 
4 - H y d r o x y p r o l i n e 8 2 . 2 + 4 . 5 4 4 . 6 ± 2 . 7 * 6 8 . 3 ± 4 . 6 
H a l f - c y s t i n e 2 6 . 1 + 1 . 6 24.8(N=3) 8.1(N=1) 
H y d r o x y l y s i n e 2 4 . 9 ± 1 . 0 1 6 . 1 ± 0 . 3 * 2 1 . 0 ± 1 . 5 * * 
L y s i n e 2 0 . 4 ± 1 . 0 3 4 . 1 ± 1 . 7 * 2 8 . 4 1 2 . 4 * 
P r o l i n e 6 2 . 5 ± 1 . 7 6 5 . 9 ± 4 . 0 6 6 . 5 ± 2 . 8 
G l y c i n e 2 1 0 . 5 1 4 . 1 1 5 6 . 2 1 5 . 6 * 1 9 7 . 1 + 9 . 0 
* * 0 . 0 2 <2p < 0 . 0 5 ; * 2p < 0 . 0 1 
Habib e t a l , 1 9 8 2 
mean 1 SD 
Normal A l p o r t 
? N=5 ? 
п . г . п . г . 
71+2.8 55 + 3 . 1 * 
22+1.9 1 4 . 2 + 2 . 4 * 
n . r . J 
η . r . n . r . 
n . r . n . r . 
n . r . n . r . 
*p <0.001 
DiBona,1983 
mean 1 SD 
Normal A l p o r t 
N=3 N=1 
n . r . n . r . 
72+4 67 
1511 12 
25 24 
n . r . n . r . 
65 78 
211 237 
Table 8-1 : Amino acid composition of glomerular basement membranes, as described by 
different authors. Residues per 1000 amino acid residues. 
CMPGN = chronic merabranoproliferative glomerulonephritis, CPN = chronic 
pyelonephritis, n.r. = not reported. 
study metabolism of cultured human glomeruli and tubules (Oberley et 
al., 1981; Striker and Striker, 19Θ5). 
With respect to the exact localization of the defect in Alport's 
syndrome, research has to be directed to the non-collagenous globular 
domain of the basement membrane collagen, where the Goodpasture anti­
gen has been localized (Wieslander et al., 1984; Butkowski et al., 
1985). It was well established, that glomerular basement membranes of 
at least part of the Alport patients do not react with Goodpasture an­
tiserum (Olson et al., 1980; Jenia et al., 1981; McCoy et al., 1982; 
Jeraj et al., 1983; Chapter 5). Savage et al. (1986), using a monoclo­
nal antibody against the Goodpasture antigen were unable to demonstra­
te this antigen in 10 patients. 
Elucidation of the biochemical defect in Alport's syndrome can be 
of benefit for the understanding of other diseases in which metabolic 
disturbances of the renal basement membranes are assumed. In the nail-
patella syndrome ultrastructural lesions of the glomerular basement 
membrane have been observed (Hoyer et al., 1972; Bennett et al., 1973; 
Sabnis et al., 1980). The basement membrane is irregularly thickened 
and contains fibrillar collagen-like material. In many cases a "moth-
eaten" appearance of the membrane is present due to areas of increased 
lucency. Raidt et al. (1985) observed circulating antibodies against 
collagen type IV in some patients with this disease. They supposed 
either an inherited disorder of collagen synthesis, possible due to 
enzyme defects, or an increased accessibility of the antigen of the 
collagen molecule, due to a disorder of synthesis or incorporation of 
the proteoglycans in the laminae rarae. Marked ultrastructural altera­
tions of the glomerular basement membrane were also observed in the 
Laurence-Moon-Biedl-Bardet syndrome. This syndrome is characterized by 
obesity, mental retardation, Polydactyly, retinitis pigmentosa and hy­
pogenitalism. Renal disease is not a cardinal feature of this syndro­
me, but ultrastructural changes of the glomerular basement membrane 
frequently occur; effacement of the trilaminar architecture, segmental 
and irregular thickening alternating with thinning and rarefaction, 
and accumulation of granular and fibrillar material within the glome­
rular basement membrane (Price et al., 1981). 
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Several studies on basement membrane abnormalities are present with 
respect to the congenital nephrotic syndrome, all oF them indicating 
an abnormal biochemical composition (Mahieu et al., 1976; Tryggvason, 
1977; Autio-Harmainen et al., 1985). Vernier et al. (1983) observed a 
decrease of the polyethyleneimine reactive sites in the basement 
membrane in the congenital nephrotic syndrome. In polycystic kidney 
disease dilatation of the renal tubules can be explained by an 
abnormal biochemical composition of the tubular basement membrane, 
since thickening, splitting, and multilayering of this basement 
membrane have been observed (Milutinovic and Agodoa, 1983; Kanwar and 
Carone, 1984). With respect to benign hematuria no data on basement 
membrane composition are available. It will be interesting to apply 
specific antibodies to biopsy specimens of these patients. In our 
studies using anti-collagen IV, anti-laminin, anti-fibronectin and 
anti-proteoglycan antisera, and using Goodpasture-serum, it was not 
possible to distinguish the basement membranes of benign hematuria 
from controls (Chapter 5). 
8.2. THE DIAGNOSIS OF ALPORT'S SYNDROME 
An accurate diagnosis of Alport's syndrome is still largely dependent 
on the electron microscopic examination of a renal biopsy specimen. 
The ultrastructural lesion is rather specific for the disorder, 
although its absence does not exclude the disease (Habib et al., 
1982), as some authors showed the development of the lesions within 
repeated biopsies (Beathard and Granholm, 1977; Rumpelt, 1980). In 
doubtful cases, the application of the monoclonal antibody against the 
Goodpasture antigen might be a diagnostic aid (Savage et al., 1986). 
For carrier detection in affected families, investigation of a 
quantitative sediment according to Gadeholt (1968) seems to be a 
reliable method (Chapter 5). 
The biochemical analysis of urine on collagen degradation products 
as the hydroxylysylglycosides and 3-hydroxyproline does not seem to be 
useful for the diagnostic approach of Alport's syndrome. As was shown 
in Chapter 2-4 there are no differences in the excretion rates of the 
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free and peptide-bound hydroxylysylglycosides between patients and 
controls. Probably, diFFerences in the excretion oF these glycosides 
as a reflection oF the biochemical composition of the glomerular 
basement membrane are overruled by the contribution of the more 
abundant collagen types elsewhere in the body. With respect to the 
excretion of 3-hydroxyproline, no distinctive findings have been 
reported in Alport's syndrome. In active glomerulonephritis and 
polycystic kidney disease an increased ratio between 3-hydroxyproline 
and 4-hydroxyproline was observed (Chanard et al., 1982). In Alport's 
syndrome a normal excretion of 3-hydroxyproline was found (Grünfeld, 
1985). 
Better perspectives can be offered by the investigation of basement 
membrane antigens in the urine. An extensive literature is available 
on this topic (Huttunen et al., 1976; Gazit et al., 1977; Wakashin et 
al., 1977; Batsford et al., 1978; Henriksen et al., 1978; Bygren et 
al., 1979; Huttunen et al., 1979; Schober et al., 1982; Schneider et 
al., 1983). These authors all applied an antiserum against more or 
less puriFied glomerular basement membrane compounds on concentrated 
urinary specimens. With all methods used, reactive protein fragments 
in normal urine could be demonstrated. The composition and origin oF 
these fragments has not thoroughly been investigated. The presence of 
protein fragments, absent from normal urine, or an increased excretion 
of normal compounds was reported in the congenital nephrotic syndrome 
of Finnish type (Huttunen et al., 1976, 1979), urinary tract 
infections (Gazit et al., 1977), the nephrotic syndrome (Batsford et 
al., 1978) and a large variety of other renal diseases (Wakashin et 
al., 1977; Bygren et al., 1979; Huttunen et al., 1979). Interesting 
for the present studies are the data available on Alport's syndrome. 
Huttunen et al. (1979), using a purified rabbit anti-human glomerular 
basement membrane antiserum, found four glomerular basement membrane 
antigens in normal urine, of which the third (Ag3) was predominantly 
present in the urine of one Alport patient. Since this antigen was 
also detected in the serum of a nephrectomized patient with another 
renal disorder, it probably originated from other basement membranes 
in the body. Using a similar technique, Lubec et al. (1978) observed a 
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precipitation line in the Q-zone of Immunoelectrophoresis in θ out of 
12 children suffering from the disease. In another study, urinary 
protein of 15 patients with Alport's syndrome was applied to affinity 
chromatography columns coupled to Goodpasture antiserum (Lubec and 
Shabbir, 1984). Bound antigen was eluted from the column and applied 
to Polyacrylamide gel electrophoresis. The urine of 14 out of these 15 
patients missed two peptide-bands, which were present in controls and 
patients with glomerulonephritis. Both last studies, however, lack 
sufficient control groups, and need confirmation. The approach, 
however, can be rewarding. Application of the monoclonal antibody, 
directed against the Goodpasture antigen, can open new ways to 
non-invasive diagnosis by the study of the basement membrane fragments 
in urine in Alport's syndrome, if its specificity can be confirmed 
(Savage et al., 1986). 
In the study of collagen diseases such as osteogenesis imperfecta 
gene analysis has much contributed to the knowledge of these disorders 
(Chu et al., 1983; Pope et al., 1984; Sykes et al., 1986). Our results 
in studying the X-chromosome show its usefulness also in Alport's 
syndrome. In the near future the use of DNA-probes will become a 
reliable tool for carrier-detection and prenatal diagnosis of this 
disease. Other closely linked diagnostic markers are needed to improve 
the diagnostic accuracy of this method. As the Alport gene of the 
X-linked dominant type of disease is localized on the X-chromosome 
(Menlove et al., 1985; Chapter 7), it is unlikely to find an 
association with the HLA-system, of which the genes are located at 
chromosome 6. The association described in the literature was found to 
be absent in our material (Chapter 6). The findings of Ono et al. 
(1980) and Hashimoto et al. (19Θ3) could, if confirmed, advocate 
another variant of the disease than is present in our population. It 
is generally accepted that Alport's syndrome is a heterogeneous state 
of a number of genetically distinct syndromes, with an autosomal 
dominant, an X-linked dominant and an autosomal recessive form 
(Feingold et al., 1985). 
As skin tissue is much easier to obtain than kidney tissue, the 
possibility of substituting the renal biopsy by a skin biopsy should 
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be investigated. Martinez-Hernandez and Amenta (1983) studied several 
members of one family with Alport's syndrome and found that not only 
the renal, but also the epidermal and vascular basement membranes in 
the skin were multilamellated and had an abnormal distribution of 
laminin and type IV collagen. We studied skin biopsies of three 
unrelated children with proven Alport's syndrome and were unable to 
detect ultrastructural abnormalities of the basement membranes. The 
glomerular basement membrane of the renal biopsy specimen, however, 
showed the typical lesions. We did not yet apply anti-collagen IV and 
anti-laminin antisera to the skin biopsies, but a conclusive result is 
not to be expected, as renal tissue of Alport patients shows a normal 
binding with these antisera (Habib et al., 1982; Noël et al., 1985; 
Chapter 5). Kashtan et al. (1986) observed that an anti-glomerular 
basement membrane antiserum, obtained from an Alport patient who 
developed anti-glomerular basement membrane nephritis in his renal 
allograft, identified an epidermal basement membrane antigen in 
normals. This antigen was absent completely in affected males, and 
incompletely in affected females. With respect to the investigation of 
skin biopsies, the application of monoclonal anti-glomerular basement 
membrane antibodies might supply valuable information. 
Concerning the treatment of Alport's syndrome, the future is 
gloomy. Attention has to be focused on early and exact diagnosis. 
Probes to the X-chromosome will make early detection and prenatal 
diagnosis possible, in the X-linked form of the disease. For accurate 
diagnosis careful investigation of the family forms the keystone. 
Hereby the quantitative urinary sediment is a precious tool. In a 
number of cases a renal biopsy then can be avoided. Application of a 
monoclonal antibody against the Goodpasture antigen to renal biopsy 
and/or urinary specimens might add valuable information in doubtful 
cases. For the treatment of chronic renal failure in Alport's syndrome 
it is important to remember that after transplantation anti-glomerular 
basement membrane antibodies can develop (Wilson, 1980; Milliner et 
al., 1982; Kashtan et al., 1986); The influence of these antibodies on 
the clinical course after transplantation is insufficienly known. In 
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most of the patiens these antibodies did not influence the clinical 
course. 
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APPENDIX: Families involved in the studies 
Sixteen families with Alport's syndrome were involved in the 
studies. The pedigrees of these families are depicted at the end of 
this appendix. In all but one of these families the diagnosis has been 
confirmed by the investigation of a renal biopsy specimen in at least 
one member of the family. In that family (no. 6) the diagnosis is 
assumed to be valid because of the full expression of the disease in 
the father (hematuria, typical audiography, keratoconus and endstage 
renal disease at the age of 40 years), and the pattern of 
inheritance. In the other members of the families, Alport's syndrome 
was diagnosed, if hematuria was established in a quantitative sediment 
from freshly voided urine, according to the criteria of Gadeholt 
(1968). With respect to the deceased members of the families, data 
were collected from hospital archives, as far as accessible, and from 
the family history. The study of family 1 was facilitated by the kind 
supply with all data from a former study by Dr. J.B.M.J. Trimbos, who 
participated in the investigation of an older generation of this 
family (Daneels et al., 1967). 
A total of 131 members of these families was personally examined. 
The examination consisted of a careful interview with respect to the 
family history, the investigation of a blood specimen (creatinine and 
urea) and a freshly voided urinary specimen (protein and quantitative 
sediment), and an audiography. Data on family 14 were collected by 
Dr. D. Menzel of the University of Essen (FRG). Of all persons, from 
which reliable information could be obtained (by personal 
investigation, information from hospital archives or family history), 
80 showed hematuria, 29 impairment of glomerular filtration rate (21 χ 
endstage renal disease), 35 audiologic, and 5 opthalmologic features 
typical for Alport's syndrome. One female patient (No. II-4 of family 
3) with mild renal involvement (hematuria but normal glomerular 
filtration rate) has been deaf from birth; probably this phenomenon is 
not due to Alport's syndrome. Since in our study primarily children 
were involved (adults were included only if a direct family relation 
was present) the ratio's of impaired glomerular filtration rate and 
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auditory involvement to hematuria of 29/80 and 35/80 are not 
surprising. Striking, on the other hand, is the low percentage of 
ocular features of the syndrome. Only 5 (adult) patients showed 
keratoconus. All probands from the families, and a number of other 
family members with hematuria, were investigated by an 
ophthalmologist. The macular and perimacular abnormalities, described 
in the literature, were never noted. 
Complete blood coagulation studies were performed in all probands. 
No abnormalities, especially no signs of thrombocytopenia or -pathia 
were observed, with the thrombocytecount and the bleeding time 
according to Ivy. Furthermore, thrombocyte counts as well as judgment 
of thrombocyte morphology on a blood smear were performed for 57 
members of the families (Dr. C G . van Oostrorn, Dept. of Paediatrics, 
Univ. of Nijmegen). Neither thrombocytopenia, nor macro-platelets in 
the blood smear were observed. 
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Fig.A.IiPedigrees of the investigated families. Key: upper left 
shadowed-hematuria; upper right shadowed-impaired renal 
function; lower left shadowed-deafness; lower right 
shadowed-ocular malformation. Patients in which a renal 
biopsy was performed are marked with an asterisk. 
D , 0 = male, female 
0,0 - deceased 
• , Ο = propositus, personally investigated 
О О = twin (female) 
• = abortion 
<h = 3 persons of both sexes 
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Fig. A-1 (cont.) 
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Fig. A-1 (cont.) 
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SUMMARY 
In this thesis various aspects oF the Alport's syndrome are 
discussed. The aims oF the study were to expand the knowledge oF the 
biochemical abnormality in this syndrome and to Find approaches For a 
non-invasive diagnosis. 
A survey on the literature available on Alport's syndrome is given 
in Chapter 1. As a biochemical abnormality oF the glomerular basement 
membrane is assumed to exist in this syndrome, Firstly the relevant 
inFormation on the renal basement membranes is given. Attention is 
paid to the collagenous and the non-collagenous components oF the 
basement membranes, its degradation and some oF the degradation 
products, the hydroxylysylglycosides and 3-hydroxyproline. 
Subsequently, data From the literature on Alport's syndrome are 
presented, divided in history and clinical Findings, histopathology, 
genetics and data From transplantation. 
In Chapter 2 a newly developed method For the determination oF 
hydroxylysine and its glycosides, glucosylgalactosylhydroxylysine and 
galactosylhydroxylysine, in the urine is described. Control values For 
normal children and adults are presented. Prematures and young 
children have a high and rather variable excretion oF all components, 
whereas adults have low and similar excretion rates. 
The urine oF patients suFFering From Alport's syndrome and several 
other glomerulopathies was investigated on these compounds, and the 
results are compared with those oF normals (Chapter 3). It is not 
possible to discriminate the controls and the diFFerent groups by the 
excretion oF hydroxylysine and its glycosides. 
As the urinary peptide-bound Fraction oF hydroxylysine and its 
glycosides seems to be more basement membrane collagen speci Fie than 
the Free compounds, total hydroxylysine and its glycosides were 
analyzed aFter alkaline hydrolysis oF the urinary samples. Again no 
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marked differences between normals, Alport patients, and patients 
suffering from other glomerulopathies could be established (Chapter 
4). 
The pathological observations on the renal biopsy specimens of 
patients with isolated hematuria from the last 10 years are evaluated 
and correlated with the clinical data (Chapter 5). Special attention 
is paid to the benign familial hematuria, since this disease is 
difficult to differentiate from Alport's syndrome in childhood. 
Careful examination of the family of children presenting with isolated 
hematuria is necessary for an accurate diagnosis, as well as the 
investigation of the renal biopsy specimen by all available techniques 
including electronmicroscopy. The use of an indirect immunofluo-
rescence technique with polyclonal antisera against basement membrane 
components was not of value with respect to differential diagnosis. 
Since association of Alport's syndrome with the HLA-system is 
reported in the literature, a study on linkage and association with 
this system is presented in Chapter 6. Neither linkage nor association 
are present in the material studied. 
An X-linked dominant inheritance is assumed for a majority of the 
families with Alport's syndrome. Studies on the X-chromosome are 
presented in Chapter 7. The gene of the disease could be localized in 
the middle of the long arm of the X-chromosome in the vicinity of the 
probe DXS 11. 
In the general discussion the findings obtained in these studies 
are related to the literature with respect to the localization of the 
biochemical lesion and the diagnosis of the disease. 
In the appendix the pedigrees and the clinical data of the 
families, involved in the study, are presented. 
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SAMENVATTING 
Dit proefschrift is gewijd aan een aantal verschillende aspecten 
van het syndroom van Alport. Het doel van de studie was tweeledig: 
enerzijds werd getracht het inzicht in de biochemische grondslag van 
de aandoening te vergroten, anderzijds werd een poging gedaan om tot 
een niet-invasieve diagnostiek te komen. 
Aangezien aangenomen wordt, dat het syndroom van Alport berust op 
een biochemische stoornis in het basaalmembraan-metabolisme, is het 
eerste hoofdstuk gewijd aan de literatuur betreffende de basaalmembra-
nen van de nier en de ziekte. 
Allereerst worden de relevante gegevens aangaande de collagene en 
niet-collagene bestanddelen van de basaalmembraan besproken, waarna 
aandacht besteed wordt aan de afbraak van het basaalmembraancollageen 
en enkele afbraakprodukten, 3-hydroxyproline en de glycosiden van 
hydroxylysine. Vervolgens wordt het syndroom van Alport behandeld, 
gesplitst naar geschiedenis en Symptomatologie, histopathologie, 
erfelijkheid en bevindingen na transplantatie. 
In hoofdstuk 2 wordt een nieuw ontwikkelde methode voor de 
bepaling in urine van hydroxylysine en zijn glycosiden, glucosyl-
galactosylhydroxylysine en galactosylhydroxylysine, beschreven. 
Referentiewaarden voor kinderen en volwassenen worden gegeven. Bij 
kinderen werd een hoge uitscheiding van alle componenten gevonden, met 
een grote spreiding. Bij volwassenen was de uitscheiding lager en 
vertoonde weinig spreiding. 
De urine van patiënten lijdende aan het syndroom van Alport en aan 
verschillende andere glomerulopathieën werd vervolgens onderzocht op 
deze bestanddelen (Hoofdstuk 3). Relevante verschillen tussen normalen 
en patiënten werden niet gevonden. 
Aangezien de eiwitgebonden fractie van de glycosiden een meer op 
basaalmembraancollageen gelijkende samenstelling heeft dan de vrije 
159 
fractie, werd de urine van normalen, Alport-patiënten en patiënten met 
andere glomerulaire aandoeningen onderzocht op hydroxylysine en zijn 
glycosiden na alkalische hydrolyse (Hoofdstuk 4). Op deze wijze werden 
de totale (vrije en eiwitgebonden) glycosiden gemeten. Wederom konden 
geen verschillen tussen patiënten en normalen worden aangetoond. 
De pathologisch-anatomische bevindingen in het nierbiopsiemateriaal 
van patiënten met geïsoleerde hématurie, die de afgelopen 10 jaar 
werden onderzocht, worden in hoofdstuk 5 gerelateerd aan de klinische 
gegevens. Hierbij wordt met name aandacht besteed aan de benigne 
familiaire hématurie, die op de kinderleeftijd differentiaaldiagnos-
tische problemen met het syndroom van Alport kan geven. Grondig 
onderzoek van de familie van de patiënt is, naast een nauwkeurige 
beoordeling van het nierbiopt met alle beschikbare technieken, 
inclusief electronenmicroscopie, noodzakelijk om tot een juiste 
diagnose te komen. De toepassing van polyclonale antilichamen gericht 
tegen basaalmembraancomponenten met behulp van indirecte immunofluo-
rescentie bleek niet van waarde voor de differentiële diagnostiek. 
Daar de literatuur een relatie van het syndroom van Alport met het 
HLA-systeem vermeldt, wordt in hoofdstuk 6 een onderzoek naar 
koppeling en associatie bij Nederlandse patiënten gepresenteerd. Noch 
koppeling, noch associatie werd gevonden. 
Voor de meeste families met het Alport syndroom wordt een X-
gebonden dominante erfelijkheid verondersteld. In hoofdstuk 7 wordt de 
localisatie van het Alport-gen op het X-chromosoom, m.b.v. DNA-
probes, beschreven. Het gen kon gelokaliseerd worden in het midden van 
het X-chromosoom, in de nabijheid van DXS 11. 
In de discussie worden de bevindingen van het onderzoek besproken 
en gerelateerd aan de literatuur. Suggesties worden gedaan voor verder 
onderzoek naar de aard van de biochemische laesie en de diagnostische 
mogelijkheden bij de ziekte. 
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In de appendix worden de stambomen en de klinische gegevens van de 
patiënten, die in het onderzoek participeerden, gepresenteerd. 
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STELLINGEN 
behorende bij het proefschrift 
ALPORT'S SYNDROME 
In het openbaar te verdedigen 
op vrijdag 12 december 19Θ6 
des namiddags te 1.30 uur 
door 
CORNELIS HENDRIK SCHRÖDER 
STELLINGEN 
I 
Opheldering van de biochemische samenstelling van de 
basaalmembranen van de nier is van groot belang voor het 
inzicht in de Pathogenese van een groot aantal aangeboren 
nieraandoeningen. 
II 
Bij kinderen met een geïsoleerde haematurie is 
aanzienlijk deel van de gevallen het onderzoek 
familie de sleutel tot de diagnose. 
III 
De door Habib et al. (1982) en DiBona (1983) beschreven 
afwijkingen in de biochemische samenstelling van de glomerulaire 
basaalmembraan zijn niet specifiek voor het syndroom van Alport. 
Habib, H. et al., Kidney Int. 21, 1982, S20-S28. 
DiBona, G.F., J. Lab. Clin. Med., 101, 1983, 817-820. 
IV 
Het vernietigen van medische archieven na een vastgestelde 
periode maakt in veel gevallen goed onderzoek naar erfelijke 
aandoeningen onmogelijk. 
V 
Een betrouwbare bepaling van geïoniseerd magnesium in plasma 
is, ondanks tegengestelde beweringen, nog steeds onmogelijk. 
Lanier, F. et al.. Anal. Chem. 52, 1980, 2400-2402. 
Casillas, E., Harry, D.J., Kenny, M., Anal. Biochem. 
116, 1981, 319-324. 
in een 
van de 
VI 
Pseudohypoaldosteronisme type II is een foutieve benaming 
voor een syndroom bestaande uit hypertensie, hyperkaliëmie 
en een normale glomerulaire filtratie (syndroom van Gordon). 
Gordon, R.D., Hypertension 8, 1986, 93-102. 
VII 
Bij onvoldoende groei van de kleine prematuur is onderzoek 
van de natriumstofwisseling geïndiceerd. 
Sohröder, C.H., Boon, J.M., Monnens, L.A.Ü., Ned. 
T. Geneesk. 129, 1985, 85. 
VIII 
Het participeren van algemeen kinderartsen in een dienstrooster 
neonatologie is misschien vanwege de dienstbelasting begrijpe-
lijk, maar in het licht van een verantwoorde patiëntenzorg 
onaanvaardbaar. 
IX 
Zonder adekwaat onderwijs, zowel thuis als in het ziekenhuis, 
zullen kinderen, die met haemodialyse behandeld worden, een 
ontoelaatbare achterstand oplopen. 
X 
Voor basaal medisch onderzoek is een goede samenwerking tussen 
klinische en preklinische instituten onontbeerlijk. 
XI 
Het afbreken van kerken en andere kunst- en kultuurhistorisch 
belangrijke monumenten op grond van verminderde functionele 
of economische waarde is niet te rechtvaardigen; de gehele 
bevolking is verantwoordelijk voor het behoud van deze 
monumenten. 
XII 
De universitaire behuizing van veel wetenschappelijk 
medewerkers vormt een wezenlijke belemmering voor de 
taakuitoefening. 
XIII 
Het aanvangssalaris van zogenaamde assistenten m opleiding 
(A.I.O.'s) is m e t in overeenstemming met de aan hun 
gestelde eisen en verdient derhalve herziening. 
Nijmegen, 12 december 1986 C.H. Schroder 


